<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Periodontol</journal-id><journal-id journal-id-type="publisher-id">jcpe</journal-id><journal-title-group><journal-title>Journal of Clinical Periodontology</journal-title></journal-title-group><issn pub-type="ppub">0303-6979</issn><issn pub-type="epub">1600-051X</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22093005</article-id><article-id pub-id-type="pmc">3267052</article-id><article-id pub-id-type="doi">10.1111/j.1600-051X.2011.01793.x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Periodontal Therapy</subject></subj-group></article-categories><title-group><article-title>Adjunctive daily supplementation with encapsulated fruit, vegetable and berry juice powder concentrates and clinical periodontal outcomes: a double-blind RCT</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chapple</surname><given-names>Iain L C</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Milward</surname><given-names>Michael R</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ling-Mountford</surname><given-names>Nicola</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Weston</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Carter</surname><given-names>Kevin</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Askey</surname><given-names>Keeley</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dallal</surname><given-names>Gerard E</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>De Spirt</surname><given-names>Silke</given-names></name><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name><surname>Sies</surname><given-names>Helmut</given-names></name><xref ref-type="aff" rid="au3">3</xref><xref ref-type="aff" rid="au4">4</xref></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Dina</given-names></name><xref ref-type="aff" rid="au5">5</xref></contrib><contrib contrib-type="author"><name><surname>Matthews</surname><given-names>John B</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><aff id="au1"><label>1</label><institution>Periodontal Research Group, School of Dentistry, College of Medical and Dental Sciences, University of Birmingham</institution><addr-line>Birmingham, UK</addr-line></aff><aff id="au2"><label>2</label><institution>Gerald J &amp; Dorothy R Friedman School of Nutrition Science and Policy, Tufts University</institution><addr-line>Boston, MA, USA</addr-line></aff><aff id="au3"><label>3</label><institution>Institute of Biochemistry and Molecular Biology I, Faculty of Medicine, Heinrich-Heine-University</institution><addr-line>Dusseldorf, Germany</addr-line></aff><aff id="au4"><label>4</label><institution>College of Science, King Saud University</institution><addr-line>Riyadh, Saudi Arabia</addr-line></aff><aff id="au5"><label>5</label><institution>UK National External Quality Assessment (NEQAS) for Immunology, Immunochemistry and Allergy, Department of Immunology, Northern General Hospital</institution><addr-line>Herries Road, Sheffield, UK</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Address: Professor Iain L. C. Chapple Periodontal Research Group School of Dentistry College of Medical and Dental Sciences University of Birmingham St Chads Queensway Birmingham, B4 6NN, UK E-mail: <email>i.l.c.chapple@bham.ac.uk</email></corresp><fn><p>Re-use of this article is permitted in accordancewith the Terms and Conditions set out at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms">http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms</ext-link>.</p></fn><fn><p><bold>Conflict of interests and Source of Funding</bold></p></fn><fn><p>The authors declare that they have no conflicts of interest.</p></fn><fn><p>The study was funded in part by NSA LLC, Collierville, TN, USA.</p></fn></author-notes><pub-date pub-type="ppub"><month>1</month><year>2012</year></pub-date><volume>39</volume><issue>1</issue><fpage>62</fpage><lpage>72</lpage><history><date date-type="accepted"><day>31</day><month>8</month><year>2011</year></date></history><permissions><copyright-statement>Copyright © 2012 John Wiley &amp; Sons A/S</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p></license></permissions><abstract><sec><title><offsets xml_i="5325" xml_f="5328" txt_i="11" txt_f="14">Aim</offsets></title><p><offsets xml_i="5339" xml_f="5571" txt_i="15" txt_f="247">A double-blind randomized controlled trial to determine whether dietary supplementation with fruit/vegetable/berry juice powder concentrates, simultaneously with non-surgical periodontal therapy, improved 2-month treatment outcomes.</offsets></p></sec><sec><title><offsets xml_i="5593" xml_f="5600" txt_i="249" txt_f="256">Methods</offsets></title><p><offsets xml_i="5611" xml_f="6074" txt_i="257" txt_f="720">Volunteers with chronic periodontitis were randomly assigned to one of three groups: fruit/vegetable (FV), fruit/vegetable/berry (FVB) or placebo. Supplements were taken daily during non-surgical debridement and maintenance and outcomes assessed at 2, 5 and 8 months after completion. Primary outcomes were mean probing pocket depth (PPD), clinical attachment gain, % sites bleeding on probing (% BOP) at 2 months. Adherence and plasma β-carotene were determined.</offsets></p></sec><sec><title><offsets xml_i="6096" xml_f="6103" txt_i="722" txt_f="729">Results</offsets></title><p><offsets xml_i="6114" xml_f="6198" txt_i="730" txt_f="814">Sixty-one nutritionally replete (by serum biochemistry) volunteers enrolled and 60 (</offsets><italic><offsets xml_i="6206" xml_f="6207" txt_i="814" txt_f="815">n</offsets></italic><offsets xml_i="6216" xml_f="6350" txt_i="815" txt_f="949"> = 20 per arm) completed the 2-month review. Clinical outcomes improved in all groups at 2 months, with additional improvement in PPD </offsets><italic><offsets xml_i="6358" xml_f="6364" txt_i="949" txt_f="955">versus</offsets></italic><offsets xml_i="6373" xml_f="6390" txt_i="955" txt_f="972"> placebo for FV (</offsets><italic><offsets xml_i="6398" xml_f="6399" txt_i="972" txt_f="973">p</offsets></italic><offsets xml_i="6408" xml_f="6511" txt_i="973" txt_f="1073"> &lt; 0.03). Gingival crevicular fluid volumes diminished more in supplement groups than placebo (FVB; </offsets><italic><offsets xml_i="6519" xml_f="6520" txt_i="1073" txt_f="1074">p</offsets></italic><offsets xml_i="6529" xml_f="6674" txt_i="1074" txt_f="1216"> &lt; 0.05) at 2 months, but not at later times. The % BOP (5 months) and cumulative plaque scores (8 months) were lowered more in the FV group (</offsets><italic><offsets xml_i="6682" xml_f="6683" txt_i="1216" txt_f="1217">p</offsets></italic><offsets xml_i="6692" xml_f="6704" txt_i="1217" txt_f="1226"> &lt; 0.05).</offsets></p></sec><sec><title><offsets xml_i="6726" xml_f="6737" txt_i="1228" txt_f="1239">Conclusions</offsets></title><p><offsets xml_i="6748" xml_f="7061" txt_i="1240" txt_f="1553">Adjunctive juice powder concentrates appear to improve initial pocket depth reductions in nutritionally replete patients, where plasma micronutrient bioavailability is attainable. Definitive multicentre studies in untreated and treated patients are required to ascertain the clinical significance of such changes.</offsets></p></sec></abstract><kwd-group><kwd>berry</kwd><kwd>dietary intervention</kwd><kwd>fruit</kwd><kwd>Juice Plus+</kwd><kwd>micronutrient</kwd><kwd>periodontitis</kwd><kwd>randomized controlled trials</kwd><kwd>therapy</kwd><kwd>vegetable</kwd></kwd-group></article-meta></front><body><p><offsets xml_i="7347" xml_f="8158" txt_i="1562" txt_f="2373">Periodontitis is a complex chronic inflammatory disease requiring the emergence of a pathogenic biofilm whose expression is governed by a number of host-dependent component causes. The qualitative and quantitative contributions of the various component causes to disease initiation and/or progression varies from patient to patient, resulting in a widely heterogenic clinical phenotype. Disease severity and extent also appear to be influenced by the same exposures, in conjunction with local anatomical features. Tissue destruction arises largely from a dysregulation of chronic inflammatory processes that the body's homoeostatic maintenance systems fail to resolve, resulting in a failure to eliminate pathogenic components of the subgingival biofilm and a persistence of chronic non-resolving inflammation (</offsets><xref ref-type="bibr" rid="b55"><offsets xml_i="8190" xml_f="8203" txt_i="2373" txt_f="2386">Van Dyke 2008</offsets></xref><offsets xml_i="8210" xml_f="8212" txt_i="2386" txt_f="2388">).</offsets></p><p><offsets xml_i="8219" xml_f="8325" txt_i="2389" txt_f="2495">Exposure categories believed to contribute component causes to periodontal inflammation include: genetic (</offsets><xref ref-type="bibr" rid="b38"><offsets xml_i="8357" xml_f="8380" txt_i="2495" txt_f="2518">Michalowicz et al. 1991</offsets></xref><offsets xml_i="8387" xml_f="8613" txt_i="2518" txt_f="2744">); environmental (e.g. biofilm, stress); lifestyle/behavioural (e.g. smoking, diet) and pharmacological (e.g. corticosteroids); and “nutrition”, which is influenced by lifestyle, environmental and genetic exposure categories (</offsets><xref ref-type="bibr" rid="b9"><offsets xml_i="8644" xml_f="8656" txt_i="2744" txt_f="2756">Chapple 2009</offsets></xref><offsets xml_i="8663" xml_f="8765" txt_i="2756" txt_f="2858">). Evidence is emerging for associations between such lifestyle factors and periodontal inflammation (</offsets><xref ref-type="bibr" rid="b4"><offsets xml_i="8796" xml_f="8814" txt_i="2858" txt_f="2876">Bawadi et al. 2011</offsets></xref><offsets xml_i="8821" xml_f="8823" txt_i="2876" txt_f="2878">).</offsets></p><p><offsets xml_i="8830" xml_f="8989" txt_i="2879" txt_f="3038">Epidemiological studies demonstrate that a higher intake of fruit and vegetables (FV) is associated with a lowered risk of atherogenic cardiovascular disease (</offsets><xref ref-type="bibr" rid="b28"><offsets xml_i="9021" xml_f="9042" txt_i="3038" txt_f="3059">Joshipura et al. 1999</offsets></xref><offsets xml_i="9049" xml_f="9070" txt_i="3059" txt_f="3080">), ischaemic stroke (</offsets><xref ref-type="bibr" rid="b27"><offsets xml_i="9102" xml_f="9123" txt_i="3080" txt_f="3101">Joshipura et al. 2001</offsets></xref><offsets xml_i="9130" xml_f="9147" txt_i="3101" txt_f="3118">) and mortality (</offsets><xref ref-type="bibr" rid="b30"><offsets xml_i="9179" xml_f="9196" txt_i="3118" txt_f="3135">Knekt et al. 1996</offsets></xref><offsets xml_i="9203" xml_f="9205" txt_i="3135" txt_f="3137">, </offsets><xref ref-type="bibr" rid="b47"><offsets xml_i="9237" xml_f="9257" txt_i="3137" txt_f="3157">Sauvaget et al. 2003</offsets></xref><offsets xml_i="9264" xml_f="9469" txt_i="3157" txt_f="3362">). Diets rich in vegetables and Vitamin C also appear to associate positively with better periodontal health and negatively with periodontal disease progressing more rapidly in undernourished populations (</offsets><xref ref-type="bibr" rid="b19"><offsets xml_i="9501" xml_f="9520" txt_i="3362" txt_f="3381">Enwonwu et al. 2002</offsets></xref><offsets xml_i="9527" xml_f="9628" txt_i="3381" txt_f="3482">). Given the high prevalence of periodontitis in the population (moderate disease prevalence 20–50%; </offsets><xref ref-type="bibr" rid="b31"><offsets xml_i="9660" xml_f="9677" txt_i="3482" txt_f="3499">König et al. 2010</offsets></xref><offsets xml_i="9684" xml_f="9760" txt_i="3499" txt_f="3575">) and its impact upon elevating plasma biomarkers of systemic inflammation (</offsets><xref ref-type="bibr" rid="b18"><offsets xml_i="9792" xml_f="9812" txt_i="3575" txt_f="3595">D'Aiuto et al. 2004a</offsets></xref><offsets xml_i="9819" xml_f="9821" txt_i="3595" txt_f="3597">, </offsets><xref ref-type="bibr" rid="b17"><offsets xml_i="9853" xml_f="9854" txt_i="3597" txt_f="3598">b</offsets></xref><offsets xml_i="9861" xml_f="9974" txt_i="3598" txt_f="3711">), it appears that periodontal inflammation makes a significant contribution to the systemic inflammatory burden.</offsets></p><p><offsets xml_i="9981" xml_f="10274" txt_i="3712" txt_f="4005">In recent years, strong evidence has emerged that diets rich in refined carbohydrates and saturated fats are pro-inflammatory, whereas those rich in polyunsaturated fats (fish oils), antioxidant micronutrients (fruits, berries and vegetables) and certain nuts (cashews) are anti-inflammatory (</offsets><xref ref-type="bibr" rid="b42"><offsets xml_i="10306" xml_f="10325" txt_i="4005" txt_f="4024">O'Keefe et al. 2008</offsets></xref><offsets xml_i="10332" xml_f="10484" txt_i="4024" txt_f="4176">). Pro-inflammatory diets drive oxidative stress within cells and tissues through metabolic (mitochondrial) and receptor-mediated pathways (reviewed by </offsets><xref ref-type="bibr" rid="b9"><offsets xml_i="10515" xml_f="10527" txt_i="4176" txt_f="4188">Chapple 2009</offsets></xref><offsets xml_i="10534" xml_f="10577" txt_i="4188" txt_f="4231">) and such post-prandial oxidative stress (</offsets><xref ref-type="bibr" rid="b50"><offsets xml_i="10609" xml_f="10625" txt_i="4231" txt_f="4247">Sies et al. 2005</offsets></xref><offsets xml_i="10632" xml_f="10671" txt_i="4247" txt_f="4286">), termed “meal induced inflammation” (</offsets><xref ref-type="bibr" rid="b41"><offsets xml_i="10703" xml_f="10726" txt_i="4286" txt_f="4305">O'Keefe &amp; Bell 2007</offsets></xref><offsets xml_i="10733" xml_f="10777" txt_i="4305" txt_f="4349">) positively correlates with the magnitude (</offsets><xref ref-type="bibr" rid="b20"><offsets xml_i="10809" xml_f="10829" txt_i="4349" txt_f="4369">Esposito et al. 2008</offsets></xref><offsets xml_i="10836" xml_f="10853" txt_i="4369" txt_f="4386">) and frequency (</offsets><xref ref-type="bibr" rid="b7"><offsets xml_i="10884" xml_f="10904" txt_i="4386" txt_f="4406">Ceriello et al. 2008</offsets></xref><offsets xml_i="10911" xml_f="11207" txt_i="4406" txt_f="4702">) of post-meal surges in glucose and triglycerides. The latter, a consequence of the rapid absorption of glucose and lipids into the blood stream following intake of dietary refined carbohydrate and saturated fats, gives rise to elevations in plasma levels of CRP and pro-inflammatory cytokines (</offsets><xref ref-type="bibr" rid="b39"><offsets xml_i="11239" xml_f="11258" txt_i="4702" txt_f="4721">Monnier et al. 2006</offsets></xref><offsets xml_i="11265" xml_f="11289" txt_i="4721" txt_f="4745">) and oxidative stress (</offsets><xref ref-type="bibr" rid="b9"><offsets xml_i="11320" xml_f="11332" txt_i="4745" txt_f="4757">Chapple 2009</offsets></xref><offsets xml_i="11339" xml_f="11605" txt_i="4757" txt_f="5023">). Indeed, recent evidence has demonstrated a significant role for oxidative stress in promoting bone resorption via activation of certain transcription factors (FoxOs, which decreases wnt signalling), modulated by insulin resistance and increasing age (reviewed by </offsets><xref ref-type="bibr" rid="b21"><offsets xml_i="11637" xml_f="11654" txt_i="5023" txt_f="5040">Galli et al. 2011</offsets></xref><offsets xml_i="11661" xml_f="12108" txt_i="5040" txt_f="5487">). Antioxidant micronutrients combat such pro-inflammatory cascades through modulation of oxidative stress by directly scavenging reactive oxygen species (ROS) and also by down-regulation of some redox-sensitive pro-inflammatory gene transcription factors such as nuclear factor-kappa B and activator protein-1 while up regulating anti-inflammatory gene transcription factors such as nuclear factor (erythroid-derived 2)-like 2 (Nrf2: reviewed by </offsets><xref ref-type="bibr" rid="b14"><offsets xml_i="12140" xml_f="12167" txt_i="5487" txt_f="5510">Chapple &amp; Matthews 2007</offsets></xref><offsets xml_i="12174" xml_f="12460" txt_i="5510" txt_f="5796">). Indeed, adjunctive phytonutrient supplementation using juice powder concentrates of fruit, vegetables and berries (FVB) has been shown to reduce the immediate impact of a high fat test meal upon inflammatory biomarkers and to improve flow mediated dilatation of the brachial artery (</offsets><xref ref-type="bibr" rid="b44"><offsets xml_i="12492" xml_f="12512" txt_i="5796" txt_f="5816">Plotnick et al. 2003</offsets></xref><offsets xml_i="12519" xml_f="12521" txt_i="5816" txt_f="5818">).</offsets></p><p><offsets xml_i="12528" xml_f="12557" txt_i="5819" txt_f="5848">Oxidative stress, defined as </offsets><italic><offsets xml_i="12565" xml_f="12718" txt_i="5848" txt_f="6001">an imbalance between oxidants and antioxidants in favour of the oxidants, leading to a disruption of redox signalling and control and/or molecular damage</offsets></italic><offsets xml_i="12727" xml_f="12729" txt_i="6001" txt_f="6003"> (</offsets><xref ref-type="bibr" rid="b49"><offsets xml_i="12761" xml_f="12782" txt_i="6003" txt_f="6020">Sies &amp; Jones 2007</offsets></xref><offsets xml_i="12789" xml_f="12864" txt_i="6020" txt_f="6095">) is a key pathological event underpinning periodontal tissue destruction (</offsets><xref ref-type="bibr" rid="b14"><offsets xml_i="12896" xml_f="12923" txt_i="6095" txt_f="6118">Chapple &amp; Matthews 2007</offsets></xref><offsets xml_i="12930" xml_f="12932" txt_i="6118" txt_f="6120">, </offsets><xref ref-type="bibr" rid="b6"><offsets xml_i="12963" xml_f="12981" txt_i="6120" txt_f="6138">Bullon et al. 2009</offsets></xref><offsets xml_i="12988" xml_f="12990" txt_i="6138" txt_f="6140">, </offsets><xref ref-type="bibr" rid="b21"><offsets xml_i="13022" xml_f="13039" txt_i="6140" txt_f="6157">Galli et al. 2011</offsets></xref><offsets xml_i="13046" xml_f="13140" txt_i="6157" txt_f="6251">). Since the first indirect demonstration of oxidative stress within the periodontal tissues (</offsets><xref ref-type="bibr" rid="b13"><offsets xml_i="13172" xml_f="13191" txt_i="6251" txt_f="6270">Chapple et al. 1997</offsets></xref><offsets xml_i="13198" xml_f="13291" txt_i="6270" txt_f="6363">), a body of evidence has accumulated demonstrating elevated biomarkers of oxidative stress (</offsets><xref ref-type="bibr" rid="b52"><offsets xml_i="13323" xml_f="13341" txt_i="6363" txt_f="6381">Sugano et al. 2000</offsets></xref><offsets xml_i="13348" xml_f="13350" txt_i="6381" txt_f="6383">, </offsets><xref ref-type="bibr" rid="b53"><offsets xml_i="13382" xml_f="13400" txt_i="6383" txt_f="6401">Takane et al. 2002</offsets></xref><offsets xml_i="13407" xml_f="13409" txt_i="6401" txt_f="6403">, </offsets><xref ref-type="bibr" rid="b57"><offsets xml_i="13441" xml_f="13456" txt_i="6403" txt_f="6418">Wei et al. 2004</offsets></xref><offsets xml_i="13463" xml_f="13465" txt_i="6418" txt_f="6420">, </offsets><xref ref-type="bibr" rid="b43"><offsets xml_i="13497" xml_f="13520" txt_i="6420" txt_f="6443">Panjamurthy et al. 2005</offsets></xref><offsets xml_i="13527" xml_f="13529" txt_i="6443" txt_f="6445">, </offsets><xref ref-type="bibr" rid="b16"><offsets xml_i="13561" xml_f="13580" txt_i="6445" txt_f="6464">D'Aiuto et al. 2010</offsets></xref><offsets xml_i="13587" xml_f="13617" txt_i="6464" txt_f="6494">) and antioxidant compromise (</offsets><xref ref-type="bibr" rid="b13"><offsets xml_i="13649" xml_f="13668" txt_i="6494" txt_f="6513">Chapple et al. 1997</offsets></xref><offsets xml_i="13675" xml_f="13677" txt_i="6513" txt_f="6515">, </offsets><xref ref-type="bibr" rid="b10"><offsets xml_i="13709" xml_f="13713" txt_i="6515" txt_f="6519">2002</offsets></xref><offsets xml_i="13720" xml_f="13722" txt_i="6519" txt_f="6521">, </offsets><xref ref-type="bibr" rid="b5"><offsets xml_i="13753" xml_f="13770" txt_i="6521" txt_f="6538">Brock et al. 2004</offsets></xref><offsets xml_i="13777" xml_f="13779" txt_i="6538" txt_f="6540">, </offsets><xref ref-type="bibr" rid="b43"><offsets xml_i="13811" xml_f="13834" txt_i="6540" txt_f="6563">Panjamurthy et al. 2005</offsets></xref><offsets xml_i="13841" xml_f="13843" txt_i="6563" txt_f="6565">, </offsets><xref ref-type="bibr" rid="b16"><offsets xml_i="13875" xml_f="13894" txt_i="6565" txt_f="6584">D'Aiuto et al. 2010</offsets></xref><offsets xml_i="13901" xml_f="14196" txt_i="6584" txt_f="6879">) in periodontitis patients. Recent data from our own laboratory demonstrated that the antioxidant depletion manifest locally within the periodontal tissues appears to be an effect rather than a cause of the oxidative stress, which develops during periodontal inflammation (Chapple et al. 2007, </offsets><xref ref-type="bibr" rid="b22"><offsets xml_i="14228" xml_f="14245" txt_i="6879" txt_f="6896">Grant et al. 2010</offsets></xref><offsets xml_i="14252" xml_f="14490" txt_i="6896" txt_f="7134">). Nevertheless, it is biologically plausible that boosting the antioxidant micronutritional status of patients may have preventive and/or adjunctive therapeutic benefit, in particular in those patients who show micronutrient deficiency (</offsets><xref ref-type="bibr" rid="b54"><offsets xml_i="14522" xml_f="14548" txt_i="7134" txt_f="7156">Tonetti &amp; Chapple 2011</offsets></xref><offsets xml_i="14555" xml_f="14557" txt_i="7156" txt_f="7158">).</offsets></p><p><offsets xml_i="14564" xml_f="15063" txt_i="7159" txt_f="7658">The potential impact of diet upon periodontal inflammatory status was recently illustrated in a Swiss study, which found that when 10 adults were placed in a “stone-age” environment for 4 weeks, with negligible oral hygiene and diets were “stone-age” in nature (id est. low in simple sugars and high in antioxidant micronutrients, fish oils and fibre), they remarkably demonstrated significant decreases in gingival bleeding and probing depths, despite significant increases in plaque accumulation (</offsets><xref ref-type="bibr" rid="b3"><offsets xml_i="15094" xml_f="15117" txt_i="7658" txt_f="7681">Baumgartner et al. 2009</offsets></xref><offsets xml_i="15124" xml_f="15126" txt_i="7681" txt_f="7683">).</offsets></p><p><offsets xml_i="15133" xml_f="15297" txt_i="7684" txt_f="7848">Recent case–control studies have demonstrated that periodontitis patients have significantly lower serum antioxidant micronutrient levels than unaffected controls (</offsets><xref ref-type="bibr" rid="b5"><offsets xml_i="15328" xml_f="15345" txt_i="7848" txt_f="7865">Brock et al. 2004</offsets></xref><offsets xml_i="15352" xml_f="15354" txt_i="7865" txt_f="7867">, </offsets><xref ref-type="bibr" rid="b43"><offsets xml_i="15386" xml_f="15409" txt_i="7867" txt_f="7890">Panjamurthy et al. 2005</offsets></xref><offsets xml_i="15416" xml_f="15418" txt_i="7890" txt_f="7892">, </offsets><xref ref-type="bibr" rid="b32"><offsets xml_i="15450" xml_f="15469" txt_i="7892" txt_f="7911">Konopka et al. 2007</offsets></xref><offsets xml_i="15476" xml_f="15552" txt_i="7911" txt_f="7987">), and also compromised gingival crevicular fluid (GCF) antioxidant status (</offsets><xref ref-type="bibr" rid="b10"><offsets xml_i="15584" xml_f="15603" txt_i="7987" txt_f="8006">Chapple et al. 2002</offsets></xref><offsets xml_i="15610" xml_f="15612" txt_i="8006" txt_f="8008">, </offsets><xref ref-type="bibr" rid="b11"><offsets xml_i="15644" xml_f="15649" txt_i="8008" txt_f="8013">2007b</offsets></xref><offsets xml_i="15656" xml_f="15658" txt_i="8013" txt_f="8015">, </offsets><xref ref-type="bibr" rid="b5"><offsets xml_i="15689" xml_f="15706" txt_i="8015" txt_f="8032">Brock et al. 2004</offsets></xref><offsets xml_i="15713" xml_f="15926" txt_i="8032" txt_f="8245">). Non-surgical periodontal therapy has been shown to restore certain antioxidant components in a process attributed to reducing levels of oxidative stress secondary to the resolution of periodontal inflammation (</offsets><xref ref-type="bibr" rid="b8"><offsets xml_i="15957" xml_f="15976" txt_i="8245" txt_f="8264">Chapple et al. 2007</offsets></xref><offsets xml_i="15983" xml_f="16311" txt_i="8264" txt_f="8592">). However, non-surgical therapy did not restore levels of the important small molecule antioxidant species, glutathione (GSH), although the ratio of GSH to its oxidized counterpart was restored, implying at least a restoration of the redox balance within periodontal cells and tissues following successful periodontal therapy (</offsets><xref ref-type="bibr" rid="b22"><offsets xml_i="16343" xml_f="16360" txt_i="8592" txt_f="8609">Grant et al. 2010</offsets></xref><offsets xml_i="16367" xml_f="16593" txt_i="8609" txt_f="8835">). Large scale epidemiological studies also consistently support a strong inverse association between serum antioxidant micronutrient concentrations and periodontitis prevalence and severity, in several different populations (</offsets><xref ref-type="bibr" rid="b40"><offsets xml_i="16625" xml_f="16644" txt_i="8835" txt_f="8854">Nishada et al. 2000</offsets></xref><offsets xml_i="16651" xml_f="16653" txt_i="8854" txt_f="8856">, </offsets><xref ref-type="bibr" rid="b2"><offsets xml_i="16684" xml_f="16705" txt_i="8856" txt_f="8877">Amarasena et al. 2005</offsets></xref><offsets xml_i="16712" xml_f="16714" txt_i="8877" txt_f="8879">, </offsets><xref ref-type="bibr" rid="b1"><offsets xml_i="16745" xml_f="16764" txt_i="8879" txt_f="8898">Amaliya et al. 2007</offsets></xref><offsets xml_i="16771" xml_f="16773" txt_i="8898" txt_f="8900">, </offsets><xref ref-type="bibr" rid="b8"><offsets xml_i="16804" xml_f="16823" txt_i="8900" txt_f="8919">Chapple et al. 2007</offsets></xref><offsets xml_i="16830" xml_f="16832" txt_i="8919" txt_f="8921">, </offsets><xref ref-type="bibr" rid="b34"><offsets xml_i="16864" xml_f="16882" txt_i="8921" txt_f="8939">Linden et al. 2009</offsets></xref><offsets xml_i="16889" xml_f="16892" txt_i="8939" txt_f="8942">). </offsets><xref ref-type="bibr" rid="b25"><offsets xml_i="16924" xml_f="16945" txt_i="8942" txt_f="8963">Jenzsch et al. (2009)</offsets></xref><offsets xml_i="16952" xml_f="17484" txt_i="8963" txt_f="9495"> demonstrated that diets rich in vegetables, fruits, legumes and dairy products, when employed as the only intervention, significantly improved pocket depth and gingival inflammation in periodontitis patients with metabolic syndrome. The reported data point towards the biological plausibility of beneficial periodontal outcomes being derived from phytonutritional interventions of antioxidant micronutrients, acting by direct scavenging of ROS, and also by modulation of redox-sensitive pro-inflammatory gene transcription factors.</offsets></p><p><offsets xml_i="17491" xml_f="17624" txt_i="9496" txt_f="9629">There remains a paucity of data from prospective intervention studies on the role of nutrition in the pathogenesis of periodontitis (</offsets><xref ref-type="bibr" rid="b56"><offsets xml_i="17656" xml_f="17682" txt_i="9629" txt_f="9655">van der Velden et al. 2011</offsets></xref><offsets xml_i="17689" xml_f="17871" txt_i="9655" txt_f="9837">). Specifically, there are no reports from placebo-controlled randomized trials on the efficacy of nutritional supplements upon periodontal outcomes. Therefore, we hypothesized that:</offsets></p><list list-type="alpha-lower"><list-item><p><offsets xml_i="17919" xml_f="18239" txt_i="9838" txt_f="10158">Daily supplementation with a primarily antioxidant juice powder phytonutrient (Juice Plus+®-FV) would significantly improve treatment outcomes over placebo supplementation, at 3 months post-therapy commencement (2 months post-therapy completion), when used as an adjunct to conventional non-surgical periodontal therapy.</offsets></p></list-item><list-item><p><offsets xml_i="18269" xml_f="18412" txt_i="10159" txt_f="10302">Triple therapy with the above supplement (Juice Plus+®-FVB) would produce additional treatment benefit over dual therapy (FV) and over placebo.</offsets></p></list-item><list-item><p><offsets xml_i="18442" xml_f="18547" txt_i="10303" txt_f="10408">Improved treatment outcomes with the supplement will be maintained at 9 months post-therapy commencement.</offsets></p></list-item></list><p><offsets xml_i="18573" xml_f="19008" txt_i="10409" txt_f="10844">The aim of this preliminary investigator-led study was to ascertain whether or not daily dietary supplementation with capsules containing primarily FVB juice powder concentrates (Juice Plus+®; NSA LLC, Collierville, TN, USA), taken during standard non-surgical periodontal therapy (no pre-dosing), improved clinical outcomes of periodontal treatment 2 months following completion of non-surgical therapy (simultaneous supplementation).</offsets></p><sec sec-type="materials|methods"><title><offsets xml_i="19053" xml_f="19073" txt_i="10845" txt_f="10865">Material and methods</offsets></title><sec><title><offsets xml_i="19093" xml_f="19120" txt_i="10866" txt_f="10893">Study ethics and governance</offsets></title><p><offsets xml_i="19131" xml_f="19572" txt_i="10894" txt_f="11335">This was an investigator-led, three-arm, placebo-controlled, double-blind randomized intervention study (NCT00952536) and was approved by South Birmingham Local Research Ethics Committee (05/Q2707/252), and research governance was overseen by South Birmingham Primary Care Trust Research Management and Governance (Project Number – SouthDent116/742). The study was conducted in accordance with international Good Clinical Practice standards.</offsets></p></sec><sec><title><offsets xml_i="19594" xml_f="19621" txt_i="11337" txt_f="11364">Study design and volunteers</offsets></title><p><offsets xml_i="19632" xml_f="19644" txt_i="11365" txt_f="11377">Volunteers (</offsets><italic><offsets xml_i="19652" xml_f="19653" txt_i="11377" txt_f="11378">n</offsets></italic><offsets xml_i="19662" xml_f="19949" txt_i="11378" txt_f="11665"> = 61) were recruited from new patient consultation clinics by one study team member (P. W.), and were both non-smokers and medically healthy by medical history questionnaire. A rolling recruitment protocol was adopted and non-smokers selected, as smoking impacts upon oxidative stress (</offsets><xref ref-type="bibr" rid="b14"><offsets xml_i="19981" xml_f="20008" txt_i="11665" txt_f="11688">Chapple &amp; Matthews 2007</offsets></xref><offsets xml_i="20015" xml_f="21049" txt_i="11688" txt_f="12719">) and was deemed to be a likely confounder of study outcomes. Volunteers were aged between 30 and 60 years, either men or women, and had chronic periodontitis as defined by a minimum of two sites per quadrant with pocketing or interproximal attachment loss of &gt;6 mm and one-third radiographic bone loss. The following exclusion criteria were applied: patients with aggressive disease, patients with physical or mental disability, pregnant women, patients whose medical history may place them at risk of complications from periodontal therapy (e.g. need for antibiotic prophylaxis, Warfarinised patients), patients taking long-term antimicrobial or anti-inflammatory drugs, patients unable to swallow capsules, patients unable to provide informed consent, current smokers (or within 5 years), patients taking regular vitamin supplementation. The study was designed to exit 60 volunteers at 9 months following recruitment (8 months following completion of non-surgical treatment) and was conducted over a 4.5-year period (2005–2010).</offsets></p><p><offsets xml_i="21056" xml_f="21378" txt_i="12720" txt_f="13042">Volunteers were provided with a detailed information sheet and allowed 2 weeks to consider their participation, prior to obtaining their informed consent and enrolment. As volunteers were enrolled (by M. M.) they were allocated sequential study numbers (by K. A.) and provided with their capsules, sufficient for 3 months.</offsets></p><p><offsets xml_i="21385" xml_f="21540" txt_i="13043" txt_f="13198">Randomization was performed by the study statistician (G. D.), who was independent of the clinical study team and site, using a computer-generated program </offsets><ext-link ext-link-type="uri" xlink:href="http://www.randomization.com"><offsets xml_i="21612" xml_f="21640" txt_i="13198" txt_f="13226">http://www.randomization.com</offsets></ext-link><offsets xml_i="21651" xml_f="21796" txt_i="13226" txt_f="13371"> (volunteer numbers generated from 001 to 070 to allow for loss of up to 10 participants). The capsules were supplied in pre-labelled containers.</offsets></p><p><offsets xml_i="21803" xml_f="22256" txt_i="13372" txt_f="13825">Baseline measures were also collected at the enrolment visit, prior to which volunteers were asked to fast overnight, not to brush and not to chew gum or drink within 2 h of their appointment. Protocol adherence was checked prior to sample collection, and patients were re-appointed if necessary. Biological samples were sequentially collected. The GCF from three deep sites (≥6 mm) and three shallow sites (≤3 mm) was collected as previously reported (</offsets><xref ref-type="bibr" rid="b8"><offsets xml_i="22287" xml_f="22306" txt_i="13825" txt_f="13844">Chapple et al. 2007</offsets></xref><offsets xml_i="22313" xml_f="22600" txt_i="13844" txt_f="14131">) and deep sites were pooled, on a volunteer and visit basis, as were samples from the three shallow sites. The GCF sampling was followed by a venous blood sample, probing pocket depth (PPD) and recession measures, bleeding scores, gingival colour index [Modified Gingival Index (MGI) – </offsets><xref ref-type="bibr" rid="b35"><offsets xml_i="22632" xml_f="22650" txt_i="14131" txt_f="14149">Lobene et al. 1986</offsets></xref><offsets xml_i="22657" xml_f="22679" txt_i="14149" txt_f="14171">] and plaque indices (</offsets><xref ref-type="fig" rid="fig01"><offsets xml_i="22712" xml_f="22718" txt_i="14171" txt_f="14177">Fig. 1</offsets></xref><offsets xml_i="22725" xml_f="23521" txt_i="14177" txt_f="14973">). Patients then had scaling and root surface debridement performed on a quadrant by quadrant basis within 1 month and over four visits. At each visit, adherence was re-checked and recorded. Capsule re-supply occurred at recall visits and patients were recalled at 2, 5 and 8 months following completion of the last session of instrumentation. At each recall visit, clinical samples and measurements were repeated and volunteers exited the study at the 8-month recall appointment, when capsule containers were returned and counted. Volunteers were also asked to maintain a supplement diary recording of how many capsules had been missed. If further therapy was required at this stage, as judged by clinical examination, it was performed by the same therapist (N. L.-M.), but outside of the study.</offsets></p><fig id="fig01" position="float"><label><offsets xml_i="23565" xml_f="23571" txt_i="14974" txt_f="14980">Fig. 1</offsets></label><caption><p><offsets xml_i="23591" xml_f="23608" txt_i="14980" txt_f="14997">Study flow chart.</offsets></p></caption><graphic xlink:href="jcpe0039-0062-f1"></graphic></fig><p><offsets xml_i="23680" xml_f="24328" txt_i="14998" txt_f="15646">All volunteers completed standard non-surgical periodontal therapy, which was performed by a single operator (N. L.-M.; 15 years experience and MPhil degree in clinical periodontal trials) within 4 weeks of commencing treatment and all indices were recorded by a single GCP-trained examiner (M. M.). Scaling and debridement was performed using a traditional quadrant by quadrant protocol, using a single ultrasonic (Densply CavitronPlus SPS; Densply UK) device and FSI-100 inserts, and Gracey curettes (LM-Dental UK). Treatment was performed systematically until the root surfaces were considered sufficiently clean, each quadrant taking 30–45 min.</offsets></p><p><offsets xml_i="24335" xml_f="24480" txt_i="15647" txt_f="15792">Patients commenced their assigned capsule supplement at their study enrolment study visit, within 1 week of physical instrumentation commencing (</offsets><xref ref-type="fig" rid="fig01"><offsets xml_i="24513" xml_f="24519" txt_i="15792" txt_f="15798">Fig. 1</offsets></xref><offsets xml_i="24526" xml_f="24774" txt_i="15798" txt_f="16046">) and continued supplementation during treatment (1 month) and also for 8 months of maintenance (total 9 months of supplementation). Compliance was checked by capsule count and also by analysing serum β-carotene levels. There were three study arms:</offsets></p><list list-type="simple"><list-item><p><offsets xml_i="24817" xml_f="24978" txt_i="16047" txt_f="16208">Test 1 – Six capsules daily containing the total equivalent of four FV capsules, and two placebo capsules during periodontal therapy and for 8 months thereafter.</offsets></p></list-item><list-item><p><offsets xml_i="25008" xml_f="25095" txt_i="16209" txt_f="16296">Test 2 – Six FVB capsules daily during periodontal therapy and for 8 months thereafter.</offsets></p></list-item><list-item><p><offsets xml_i="25125" xml_f="25133" txt_i="16297" txt_f="16305">Control </offsets><italic><offsets xml_i="25141" xml_f="25142" txt_i="16305" txt_f="16306">–</offsets></italic><offsets xml_i="25151" xml_f="25234" txt_i="16306" txt_f="16389"> Six placebo capsules daily during periodontal therapy and for 8 months thereafter.</offsets></p></list-item></list><p><offsets xml_i="25260" xml_f="25374" txt_i="16390" txt_f="16504">In all three study groups, capsules were taken with food twice daily (three in the morning, three in the evening).</offsets></p></sec><sec><title><offsets xml_i="25396" xml_f="25412" txt_i="16506" txt_f="16522">Outcome measures</offsets></title><p><offsets xml_i="25423" xml_f="25907" txt_i="16523" txt_f="17007">Primary outcome measures were (1) reductions in PPDs (mean per patient reduction in PPD), (2) reduction in percentage sites bleeding on probing (% BOP) from the marginal tissues (as a primary outcome measure of tissue inflammation), and (3) mean increase in clinical attachment level (CAL) at the 2-month post-therapy recall visit (3 months post-therapy commencement). Secondary outcome measures were reductions in GCF volume from both deep and shallow sites, gingival redness (MGI – </offsets><xref ref-type="bibr" rid="b35"><offsets xml_i="25939" xml_f="25957" txt_i="17007" txt_f="17025">Lobene et al. 1986</offsets></xref><offsets xml_i="25964" xml_f="25992" txt_i="17025" txt_f="17053">), cumulative plaque index (</offsets><xref ref-type="bibr" rid="b36"><offsets xml_i="26024" xml_f="26042" txt_i="17053" txt_f="17071">Lobene et al. 1982</offsets></xref><offsets xml_i="26049" xml_f="26305" txt_i="17071" txt_f="17324">) and recession. Although not part of the original protocol, a decision was made to additionally express (4) pocket depth reductions as “number of residual sites &gt;4 mm”, consistent with contemporary studies published subsequent to protocol preparation (</offsets><xref ref-type="bibr" rid="b59"><offsets xml_i="26337" xml_f="26358" txt_i="17324" txt_f="17345">Wennström et al. 2005</offsets></xref><offsets xml_i="26365" xml_f="26367" txt_i="17345" txt_f="17347">).</offsets></p><p><offsets xml_i="26374" xml_f="27162" txt_i="17348" txt_f="18136">Probing measures were performed in duplicate at six sites per tooth (two marginal and four proximal) with a constant force (UNC CP-15 markings – 0.2 N force) probe and where differences between duplicate measures of greater than 1 mm arose, a third measure was taken. The mean of the two closest measures was used. Mean probing attachment (derived from pocket depth + recession), and PPD measures per subject were calculated at each examination point (baseline, 2, 5 and 8 months post-therapy). Marginal bleeding was recorded dichotomously (four sites per tooth, mesial, distal, mid-facial, mid-lingual) and expressed as mean percentage sites bleeding on probing (% BOP) per subject at each examination point. Plaque levels were quantified using a modification of the Quigley-Hein index (</offsets><xref ref-type="bibr" rid="b36"><offsets xml_i="27194" xml_f="27212" txt_i="18136" txt_f="18154">Lobene et al. 1982</offsets></xref><offsets xml_i="27219" xml_f="27368" txt_i="18154" txt_f="18303">) and expressed as a whole mouth total (cumulative) score per volunteer at each examination point. The study visits and procedures are summarized in </offsets><xref ref-type="fig" rid="fig01"><offsets xml_i="27401" xml_f="27407" txt_i="18303" txt_f="18309">Fig. 1</offsets></xref><offsets xml_i="27414" xml_f="27554" txt_i="18309" txt_f="18449">. Outcomes at the 5- and 8-month recall visits were considered secondary outcomes, as pathogenic biofilm changes are evident at this stage (</offsets><xref ref-type="bibr" rid="b46"><offsets xml_i="27586" xml_f="27606" txt_i="18449" txt_f="18469">Quirynen et al. 2005</offsets></xref><offsets xml_i="27613" xml_f="27667" txt_i="18469" txt_f="18523">) and may lead to early signs of recalcitrant disease.</offsets></p></sec><sec><title><offsets xml_i="27689" xml_f="27717" txt_i="18525" txt_f="18553">Biological samples collected</offsets></title><p><offsets xml_i="27728" xml_f="27962" txt_i="18554" txt_f="18788">Gingival crevicular fluid samples were collected over 30 s using Periopaper™ (Oraflow Inc., Smithtown, NY, USA) strips from the mesio-buccal aspects of the three deep and three shallow molar sites per subject as previously described (</offsets><xref ref-type="bibr" rid="b5"><offsets xml_i="27993" xml_f="28010" txt_i="18788" txt_f="18805">Brock et al. 2004</offsets></xref><offsets xml_i="28017" xml_f="28111" txt_i="18805" txt_f="18899">). Volumes were read on a pre-calibrated Periotron 8000™ according to standard methodologies (</offsets><xref ref-type="bibr" rid="b12"><offsets xml_i="28143" xml_f="28162" txt_i="18899" txt_f="18918">Chapple et al. 1999</offsets></xref><offsets xml_i="28169" xml_f="28171" txt_i="18918" txt_f="18920">).</offsets></p><p><offsets xml_i="28178" xml_f="28296" txt_i="18921" txt_f="19039">Blood was collected into Vacutainer™ (NHS supplies, Alfreton, Derbyshire, UK) tubes for serum and plasma preparation (</offsets><italic><offsets xml_i="28304" xml_f="28314" txt_i="19039" txt_f="19049">vide infra</offsets></italic><offsets xml_i="28323" xml_f="28390" txt_i="19049" txt_f="19116">). Platelet depleted plasma was prepared by centrifugation at 1000 </offsets><italic><offsets xml_i="28398" xml_f="28399" txt_i="19116" txt_f="19117">g</offsets></italic><offsets xml_i="28408" xml_f="28791" txt_i="19117" txt_f="19500"> for 30 min. (4°C). Serum was aliquoted into cryogenic vials, snap frozen and stored at −80°C for subsequent analysis of β-carotene and vitamin E. For vitamin C assay, 0.75 ml metaphosphoric acid (100 g/l) was added to 0.75 ml plasma to precipitate proteins, prior to storage at −80°C. All samples were stored in the dark and kept free from direct sunlight at all stages of handling.</offsets></p></sec><sec><title><offsets xml_i="28813" xml_f="28826" txt_i="19502" txt_f="19515">Test products</offsets></title><p><offsets xml_i="28837" xml_f="29089" txt_i="19516" txt_f="19768">The verum test capsules are marketed commercially as Juice Plus+® and contain a fine, granular powder, encapsulated in a size 00 gelatin capsule. The placebo test capsules were of identical appearance and contained primarily microcrystalline cellulose.</offsets></p><p><offsets xml_i="29096" xml_f="29385" txt_i="19769" txt_f="20058">The FV capsule contents consisted primarily of a blended FV pulp and juice powder concentrate derived from Acerola cherry, apple, beet, beetroot, broccoli, cabbage, carrot, cranberry, dates, garlic, kale, orange, peach, papaya, parsley, pineapple, prune, spinach, sugar beet, tomato, with </offsets><italic><offsets xml_i="29393" xml_f="29411" txt_i="20058" txt_f="20076">Spirulina pacifica</offsets></italic><offsets xml_i="29420" xml_f="29422" txt_i="20076" txt_f="20078">, </offsets><italic><offsets xml_i="29430" xml_f="29455" txt_i="20078" txt_f="20103">Lactobacillus acidophilus</offsets></italic><offsets xml_i="29464" xml_f="29490" txt_i="20103" txt_f="20129">, rice bran, oat bran and </offsets><italic><offsets xml_i="29498" xml_f="29515" txt_i="20129" txt_f="20146">Dunaliella salina</offsets></italic><offsets xml_i="29524" xml_f="29891" txt_i="20146" txt_f="20513">. These active ingredients were supplemented to provide declared totals (per daily dose) of β-carotene (7.5 mg), vitamin E (46 mg), vitamin C (200 mg) and folic acid (400 μg). Although the phytonutrient capsules are known to contain polyphenolic antioxidant micronutrients, these vary according to growing and harvest conditions and absolute levels were not analysed.</offsets></p><p><offsets xml_i="29898" xml_f="30725" txt_i="20514" txt_f="21341">The FVB capsule contents consisted primarily of a blended fruit, berry and vegetable pulp and juice powder concentrate. In addition to all the components within the FV capsules, FVB capsules also contained material derived from blackberry, black currant, blueberry, bilberry, concord grape, elderberry, raspberry, red currant, green tea, ginger root, artichoke leaf, grape seed extract in addition to arginine, carnitine and co-Enzyme Q10. These active ingredients were supplemented to provide declared totals (per daily dose) of β-carotene (7.5 mg), vitamin E (66 mg), vitamin C (222 mg) and folic acid (640 μg). Small quantities of anti-caking agents (calcium carbonate, magnesium oxide, magnesium stearate, silicon dioxide, cellulose) and thickeners (citrus pectin, guar gum) are added to assist the manufacture of capsules.</offsets></p></sec><sec><title><offsets xml_i="30747" xml_f="30782" txt_i="21343" txt_f="21378">β-Carotene analysis (for adherence)</offsets></title><p><offsets xml_i="30793" xml_f="31081" txt_i="21379" txt_f="21667">Adherence to supplement usage was assessed by residual capsule counts and a supplement adherence diary at recall visits and also biochemically by analysis of serum β-carotene levels. β-carotene was determined by HPLC using isocratic elution, a reversed phase column (pKb-100, 250 × 4.6 mm</offsets><sup><offsets xml_i="31086" xml_f="31087" txt_i="21667" txt_f="21668">2</offsets></sup><offsets xml_i="31093" xml_f="31507" txt_i="21668" txt_f="22082">; Supelco, Bellefonte, PA, USA), protected by a guard column (4.6 × 4.6 mm²) with the same stationary phase and a Merck-Hitachi L-7100 pump connected with a Merck-Hitachi UV/Vis detector (Merck-Hitachi, Darmstadt, Germany). β-carotene was detected at 450 nm and the concentration calculated from external calibration curves generated with original standard compounds and internal standards as previously reported (</offsets><xref ref-type="bibr" rid="b51"><offsets xml_i="31539" xml_f="31556" txt_i="22082" txt_f="22099">Stahl et al. 1993</offsets></xref><offsets xml_i="31563" xml_f="31565" txt_i="22099" txt_f="22101">).</offsets></p></sec><sec><title><offsets xml_i="31587" xml_f="31643" txt_i="22103" txt_f="22159">Plasma vitamin E and vitamin C determination at baseline</offsets></title><p><offsets xml_i="31654" xml_f="31866" txt_i="22160" txt_f="22372">These analyses at baseline were performed to assess whether or not any of the volunteers were vitamin deficient. Alpha-tocopherol was extracted and detected simultaneously with the UV/VIS detector set at 292 nm (</offsets><xref ref-type="bibr" rid="b45"><offsets xml_i="31898" xml_f="31918" txt_i="22372" txt_f="22392">Polidori et al. 2001</offsets></xref></p></sec><sec><title><offsets xml_i="31947" xml_f="31989" txt_i="22394" txt_f="22436">Power calculation and statistical analysis</offsets></title><p><offsets xml_i="32000" xml_f="32841" txt_i="22437" txt_f="23278">The reported study was the first of its type to the authors’ knowledge and therefore a power calculation based upon mean (±SD) outcomes from pilot work was not possible for antioxidant outcomes. However, using the primary outcome measure of reduction in PPD and assuming a mean additional PPD reduction in the supplement groups of 0.4 mm (as this has been demonstrated in pharmacological interventions) over non-surgical therapy alone, 17 volunteers per treatment group were needed to complete the study for a two-sided test of equality of means at the 0.05 level of significance with 80% power. This was based on accepted mean PPD reductions for mild to moderate periodontitis of 1 mm (moderate) to 2 mm (deep sites) with non-surgical therapy, and also upon data from a previous study that demonstrated mean PPD reductions of 1.1 ± 0.4 mm (</offsets><xref ref-type="bibr" rid="b8"><offsets xml_i="32872" xml_f="32891" txt_i="23278" txt_f="23297">Chapple et al. 2007</offsets></xref><offsets xml_i="32898" xml_f="33036" txt_i="23297" txt_f="23435">). The study was powered to detect differences between test and placebo groups only. A total of 61 volunteers were sequentially recruited.</offsets></p><p><offsets xml_i="33043" xml_f="33485" txt_i="23436" txt_f="23878">Statistical analysis was performed by the study statistician (G. D.) and utilized analysis of covariance, with baseline measures employed as the covariates. Tukey's Honestly Significant Difference was used to compare the three groups. Analyses were performed using SAS for Windows, version 9.2 (SAS Institute Inc., Cary, NC, USA). All tests were two-sided and a result was judged statistically significant if its observed significance level (</offsets><italic><offsets xml_i="33493" xml_f="33494" txt_i="23878" txt_f="23879">p</offsets></italic><offsets xml_i="33503" xml_f="33796" txt_i="23879" txt_f="24172">-value) was less than 0.05. An intention-to-treat (ITT) analysis was performed, employing data from all subjects regardless of adherence to treatment. Serum β-carotene concentrations were also used as a biochemical measure of adherence and/or an indirect measure of carotenoid bioavailability.</offsets></p><p><offsets xml_i="33803" xml_f="34185" txt_i="24173" txt_f="24555">Missing data: The primary outcome measures were taken as part of standard care during the subjects’ 8-month review. There was no reason for missing data to be related to treatment or outcome, but missing data were checked for any relationship to treatment assignment. Otherwise missing values were ignored in the analyses because they were deemed to be missing completely at random.</offsets></p><p><offsets xml_i="34192" xml_f="34370" txt_i="24556" txt_f="24734">Code breaking: The code was retained by the statistician and not broken until the last patient had completed their 8-month recall visit, and all data analysis had been completed.</offsets></p></sec></sec><sec><title><offsets xml_i="34398" xml_f="34405" txt_i="24737" txt_f="24744">Results</offsets></title><sec><title><offsets xml_i="34425" xml_f="34453" txt_i="24745" txt_f="24773">Volunteer flow through study</offsets></title><p><offsets xml_i="34464" xml_f="34528" txt_i="24774" txt_f="24838">The flow of patients through the study stages is illustrated in </offsets><xref ref-type="fig" rid="fig01"><offsets xml_i="34561" xml_f="34567" txt_i="24838" txt_f="24844">Fig. 1</offsets></xref><offsets xml_i="34574" xml_f="35562" txt_i="24844" txt_f="25832">. Sixty-one patients were enrolled and sixty completed the 2-month post-therapy visit, providing primary outcomes for 20 volunteers in each study group (FV, FVB and placebo). Six patients withdrew at the 2-month post-therapy visit. The reasons for withdrawal were: capsules too large to swallow, moved away from area, difficulty attending appointments, unrelated medical problems, lost to follow-up for unknown reason. One patient was withdrawn (placebo group) as they telephoned to inform that they were experiencing difficulty swallowing, and although this could not be attributed to the supplements as opposed to a respiratory tract infection, the principal investigator (I. L. C.) decided to withdraw the volunteer by telephone and to complete treatment outside of the study. This last volunteer was replaced with the 61st enrolee. To ensure groups remained balanced, whilst at the same time maintaining the blinding of the study, the statistician provided a replacement study number.</offsets></p></sec><sec><title><offsets xml_i="35584" xml_f="35627" txt_i="25834" txt_f="25877">Demographical and baseline nutritional data</offsets></title><p><offsets xml_i="35638" xml_f="35681" txt_i="25878" txt_f="25921">The volunteer demographics are recorded in </offsets><xref ref-type="table" rid="tbl1"><offsets xml_i="35715" xml_f="35722" txt_i="25921" txt_f="25928">Table 1</offsets></xref><offsets xml_i="35729" xml_f="36024" txt_i="25928" txt_f="26223">, and although more women were enrolled than men, the groups were similar with regard to age and gender. There were no baseline differences between groups in peripheral blood levels of vitamin C (range = 48–58 μmol/l) and vitamin E (range = 17–19 μmol/l), which were within SI reference ranges (</offsets><xref ref-type="table" rid="tbl1"><offsets xml_i="36058" xml_f="36065" txt_i="26223" txt_f="26230">Table 1</offsets></xref><offsets xml_i="36072" xml_f="36182" txt_i="26230" txt_f="26340">). Baseline β-carotene concentrations (range = 0.5–0.7 μmol/l) were below the low end of one reference range (</offsets><xref ref-type="bibr" rid="b60"><offsets xml_i="36214" xml_f="36224" txt_i="26340" txt_f="26350">Young 1987</offsets></xref><offsets xml_i="36231" xml_f="36274" txt_i="26350" txt_f="26393">), but within another commonly used range (</offsets><xref ref-type="bibr" rid="b24"><offsets xml_i="36306" xml_f="36325" txt_i="26393" txt_f="26412">Iverson et al. 2007</offsets></xref><offsets xml_i="36332" xml_f="36395" txt_i="26412" txt_f="26475">); however, there were no differences between the study groups.</offsets></p><table-wrap id="tbl1" position="float"><caption><p><offsets xml_i="36450" xml_f="36535" txt_i="26476" txt_f="26561">Demographical and baseline micronutrient data [mean (μmol/l) ± SD] of the test groups</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"><offsets xml_i="36638" xml_f="36648" txt_i="26562" txt_f="26572">Test group</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36696" xml_f="36699" txt_i="26572" txt_f="26575">No.</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36747" xml_f="36750" txt_i="26575" txt_f="26578">Men</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36798" xml_f="36803" txt_i="26578" txt_f="26583">Women</offsets></th><th align="center" colspan="2" rowspan="1"><offsets xml_i="36851" xml_f="36862" txt_i="26583" txt_f="26594">Age (years)</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36910" xml_f="36920" txt_i="26594" txt_f="26604">β-carotene</offsets><xref ref-type="table-fn" rid="tf1-1"><offsets xml_i="36958" xml_f="36959" txt_i="26604" txt_f="26605">*</offsets></xref><offsets xml_i="36966" xml_f="36976" txt_i="26605" txt_f="26615"> (0.9–4.6)</offsets><xref ref-type="table-fn" rid="tf1-3"><offsets xml_i="37014" xml_f="37015" txt_i="26615" txt_f="26616">†</offsets></xref><offsets xml_i="37022" xml_f="37032" txt_i="26616" txt_f="26626"> (0.2–1.6)</offsets><xref ref-type="table-fn" rid="tf1-4"><offsets xml_i="37070" xml_f="37071" txt_i="26626" txt_f="26627">‡</offsets></xref></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="37126" xml_f="37135" txt_i="26627" txt_f="26636">Vitamin C</offsets><xref ref-type="table-fn" rid="tf1-2"><offsets xml_i="37173" xml_f="37174" txt_i="26636" txt_f="26637">§</offsets></xref><offsets xml_i="37181" xml_f="37190" txt_i="26637" txt_f="26646"> (30–110)</offsets><xref ref-type="table-fn" rid="tf1-3"><offsets xml_i="37228" xml_f="37229" txt_i="26646" txt_f="26647">†</offsets></xref><offsets xml_i="37236" xml_f="37244" txt_i="26647" txt_f="26655"> (23–85)</offsets><xref ref-type="table-fn" rid="tf1-4"><offsets xml_i="37282" xml_f="37283" txt_i="26655" txt_f="26656">‡</offsets></xref></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="37338" xml_f="37347" txt_i="26656" txt_f="26665">Vitamin E</offsets><xref ref-type="table-fn" rid="tf1-1"><offsets xml_i="37385" xml_f="37386" txt_i="26665" txt_f="26666">*</offsets></xref><offsets xml_i="37393" xml_f="37401" txt_i="26666" txt_f="26674"> (18–29)</offsets><xref ref-type="table-fn" rid="tf1-3"><offsets xml_i="37439" xml_f="37440" txt_i="26674" txt_f="26675">†</offsets></xref><offsets xml_i="37447" xml_f="37455" txt_i="26675" txt_f="26683"> (12–42)</offsets><xref ref-type="table-fn" rid="tf1-4"><offsets xml_i="37493" xml_f="37494" txt_i="26683" txt_f="26684">‡</offsets></xref></th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="left" colspan="2" rowspan="1"><hr></hr></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="37985" xml_f="37994" txt_i="26684" txt_f="26693">Mean ± SD</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="38042" xml_f="38047" txt_i="26693" txt_f="26698">Range</offsets></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="38216" xml_f="38235" txt_i="26698" txt_f="26717">Fruit and vegetable</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38283" xml_f="38285" txt_i="26718" txt_f="26720">20</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38333" xml_f="38340" txt_i="26721" txt_f="26728">6 (30%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38388" xml_f="38396" txt_i="26729" txt_f="26737">14 (70%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38444" xml_f="38454" txt_i="26738" txt_f="26748">48.3 ± 8.4</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38502" xml_f="38507" txt_i="26749" txt_f="26754">35–69</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38555" xml_f="38565" txt_i="26755" txt_f="26765">0.7 ± 0.45</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38613" xml_f="38624" txt_i="26766" txt_f="26777">48.1 ± 16.2</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38672" xml_f="38682" txt_i="26778" txt_f="26788">18.3 ± 4.4</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="38737" xml_f="38763" txt_i="26789" txt_f="26815">Fruit, vegetable and berry</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38811" xml_f="38813" txt_i="26816" txt_f="26818">20</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38861" xml_f="38868" txt_i="26819" txt_f="26826">8 (40%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38916" xml_f="38924" txt_i="26827" txt_f="26835">12 (60%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38972" xml_f="38982" txt_i="26836" txt_f="26846">48.1 ± 7.4</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39030" xml_f="39035" txt_i="26847" txt_f="26852">33–58</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39083" xml_f="39092" txt_i="26853" txt_f="26862">0.6 ± 0.3</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39140" xml_f="39151" txt_i="26863" txt_f="26874">57.4 ± 17.6</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39199" xml_f="39209" txt_i="26875" txt_f="26885">18.6 ± 5.9</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="39264" xml_f="39271" txt_i="26886" txt_f="26893">Placebo</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39319" xml_f="39321" txt_i="26894" txt_f="26896">20</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39369" xml_f="39376" txt_i="26897" txt_f="26904">7 (35%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39424" xml_f="39432" txt_i="26905" txt_f="26913">13 (65%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39480" xml_f="39490" txt_i="26914" txt_f="26924">47.9 ± 6.6</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39538" xml_f="39543" txt_i="26925" txt_f="26930">38–60</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39591" xml_f="39601" txt_i="26931" txt_f="26941">0.5 ± 0.25</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39649" xml_f="39660" txt_i="26942" txt_f="26953">57.9 ± 22.0</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39708" xml_f="39718" txt_i="26954" txt_f="26964">17.2 ± 3.2</offsets></td></tr></tbody></table><table-wrap-foot><fn id="tf1-1"><label><offsets xml_i="39783" xml_f="39784" txt_i="26965" txt_f="26966">*</offsets></label><p><offsets xml_i="39795" xml_f="39801" txt_i="26966" txt_f="26972">serum.</offsets></p></fn><fn id="tf1-2"><label><offsets xml_i="39832" xml_f="39833" txt_i="26973" txt_f="26974">§</offsets></label><p><offsets xml_i="39844" xml_f="39851" txt_i="26974" txt_f="26981">plasma.</offsets></p></fn><fn id="tf1-3"><label><offsets xml_i="39882" xml_f="39883" txt_i="26982" txt_f="26983">†</offsets></label><p><offsets xml_i="39894" xml_f="39924" txt_i="26983" txt_f="27013">SI reference ranges (μmol/l) (</offsets><xref ref-type="bibr" rid="b60"><offsets xml_i="39956" xml_f="39966" txt_i="27013" txt_f="27023">Young 1987</offsets></xref><offsets xml_i="39973" xml_f="39975" txt_i="27023" txt_f="27025">).</offsets></p></fn><fn id="tf1-4"><label><offsets xml_i="40006" xml_f="40007" txt_i="27026" txt_f="27027">‡</offsets></label><p><offsets xml_i="40018" xml_f="40156" txt_i="27027" txt_f="27165">SI ranges from Iversen et al. AMA Manual of Style: a guide for authors and editors. 10th Edition, New York, Oxford University Press, 2007.</offsets></p></fn></table-wrap-foot></table-wrap></sec><sec><title><offsets xml_i="40214" xml_f="40253" txt_i="27167" txt_f="27206">Adherence/bioavailability of β-carotene</offsets></title><p><offsets xml_i="40264" xml_f="40488" txt_i="27207" txt_f="27431">The supplement diaries and capsule counts indicated that protocol adherence had been equivalent in all groups. Serum β-carotene concentrations increased significantly at 2 months in both FV and FVB groups (FV by 5.4 μmol/l, </offsets><italic><offsets xml_i="40496" xml_f="40497" txt_i="27431" txt_f="27432">p</offsets></italic><offsets xml_i="40506" xml_f="40539" txt_i="27432" txt_f="27462"> &lt; 0.0001; FVB by 3.5 μmol/l, </offsets><italic><offsets xml_i="40547" xml_f="40548" txt_i="27462" txt_f="27463">p</offsets></italic><offsets xml_i="40557" xml_f="40715" txt_i="27463" txt_f="27618"> &lt; 0.0001), but there was no change in the placebo group. The differences between the supplement and placebo groups post-supplementation were significant (</offsets><italic><offsets xml_i="40723" xml_f="40724" txt_i="27618" txt_f="27619">p</offsets></italic><offsets xml_i="40733" xml_f="40827" txt_i="27619" txt_f="27710"> &lt; 0.001) and the increase in serum β-carotene concentrations was highest in the FV group (</offsets><xref ref-type="fig" rid="fig02"><offsets xml_i="40860" xml_f="40866" txt_i="27710" txt_f="27716">Fig. 2</offsets></xref><offsets xml_i="40873" xml_f="41091" txt_i="27716" txt_f="27934">) indicating greater micronutrient bioavailability in this group compared with the FVB group, which does not appear to result from between group differences in adherence, but might have impacted upon clinical outcomes.</offsets></p><fig id="fig02" position="float"><label><offsets xml_i="41135" xml_f="41141" txt_i="27935" txt_f="27941">Fig. 2</offsets></label><caption><p><offsets xml_i="41161" xml_f="41232" txt_i="27941" txt_f="28012">Percentage change in plasma beta-carotene concentrations from baseline.</offsets></p></caption><graphic xlink:href="jcpe0039-0062-f2"></graphic></fig></sec><sec><title><offsets xml_i="41319" xml_f="41346" txt_i="28014" txt_f="28041">Changes in primary outcomes</offsets></title><p><offsets xml_i="41357" xml_f="41451" txt_i="28042" txt_f="28136">The improvement in clinical outcomes in the placebo group was consistent with the literature (</offsets><xref ref-type="bibr" rid="b15"><offsets xml_i="41483" xml_f="41492" txt_i="28136" txt_f="28145">Cobb 2002</offsets></xref><offsets xml_i="41499" xml_f="41657" txt_i="28145" txt_f="28300">) and statistically significant. This is evident from the statistically significant reduction of sites &gt;4 mm at 2, 5 and 8 months post-therapy completion (</offsets><xref ref-type="fig" rid="fig03"><offsets xml_i="41690" xml_f="41697" txt_i="28300" txt_f="28307">Fig. 3a</offsets></xref><offsets xml_i="41704" xml_f="41706" txt_i="28307" txt_f="28309">; </offsets><italic><offsets xml_i="41714" xml_f="41715" txt_i="28309" txt_f="28310">p</offsets></italic><offsets xml_i="41724" xml_f="41809" txt_i="28310" txt_f="28392"> &lt; 0.0001). Thus, after a single phase of non-surgical therapy, “closed pockets” (</offsets><xref ref-type="bibr" rid="b59"><offsets xml_i="41841" xml_f="41862" txt_i="28392" txt_f="28413">Wennström et al. 2005</offsets></xref><offsets xml_i="41869" xml_f="42006" txt_i="28413" txt_f="28550">) increased in number from an average of 70% of sites in all three groups at baseline to 98% (FV group) and 91% (FVB and placebo groups).</offsets></p><fig id="fig03" position="float"><label><offsets xml_i="42050" xml_f="42056" txt_i="28551" txt_f="28557">Fig. 3</offsets></label><caption><p><offsets xml_i="42076" xml_f="42297" txt_i="28557" txt_f="28775">Changes in primary outcomes during the study period (mean ± SD). (a) Sites &gt;4 mm deep; (b) PPD (mm); (c) CAL (mm); (d) %BOP. Bars represent comparisons with baseline. Symbols alone represent comparisons with placebo. *</offsets><italic><offsets xml_i="42305" xml_f="42306" txt_i="28775" txt_f="28776">p</offsets></italic><offsets xml_i="42315" xml_f="42330" txt_i="28776" txt_f="28788"> &lt; 0.0001; ▪</offsets><italic><offsets xml_i="42338" xml_f="42339" txt_i="28788" txt_f="28789">p</offsets></italic><offsets xml_i="42348" xml_f="42359" txt_i="28789" txt_f="28800"> = 0.002; •</offsets><italic><offsets xml_i="42367" xml_f="42368" txt_i="28800" txt_f="28801">p</offsets></italic><offsets xml_i="42377" xml_f="42390" txt_i="28801" txt_f="28811"> &lt; 0.01; +</offsets><italic><offsets xml_i="42398" xml_f="42399" txt_i="28811" txt_f="28812">p</offsets></italic><offsets xml_i="42408" xml_f="42421" txt_i="28812" txt_f="28822"> &lt; 0.03; ♦</offsets><italic><offsets xml_i="42429" xml_f="42430" txt_i="28822" txt_f="28823">p</offsets></italic><offsets xml_i="42439" xml_f="42450" txt_i="28823" txt_f="28831"> &lt; 0.05.</offsets></p></caption><graphic xlink:href="jcpe0039-0062-f3"></graphic></fig><p><offsets xml_i="42522" xml_f="42648" txt_i="28832" txt_f="28958">Other primary outcome measures, pre- and post-completion of non-surgical scaling and root surface therapy, are illustrated in </offsets><xref ref-type="fig" rid="fig03"><offsets xml_i="42681" xml_f="42690" txt_i="28958" txt_f="28967">Fig. 3b–d</offsets></xref><offsets xml_i="42697" xml_f="42729" txt_i="28967" txt_f="28999"> (and mean values documented in </offsets><xref ref-type="supplementary-material" rid="SD1"><offsets xml_i="42779" xml_f="42787" txt_i="28999" txt_f="29007">Table S1</offsets></xref><offsets xml_i="42794" xml_f="42977" txt_i="29007" txt_f="29190">). At 2, 5 and 8 months post-treatment completion there were significant reductions in mean PPD compared with baseline, consistent with literature reports for moderate periodontitis (</offsets><xref ref-type="bibr" rid="b15"><offsets xml_i="43009" xml_f="43021" txt_i="29190" txt_f="29202">Cobb CM 2002</offsets></xref><offsets xml_i="43028" xml_f="43030" txt_i="29202" txt_f="29204">; </offsets><xref ref-type="bibr" rid="b56"><offsets xml_i="43062" xml_f="43099" txt_i="29204" txt_f="29237">van der Weijden &amp; Timmermann 2002</offsets></xref><offsets xml_i="43106" xml_f="43130" txt_i="29237" txt_f="29261">) for all three groups (</offsets><italic><offsets xml_i="43138" xml_f="43139" txt_i="29261" txt_f="29262">p</offsets></italic><offsets xml_i="43148" xml_f="43293" txt_i="29262" txt_f="29404"> &lt; 0.0001). At 2 months, reductions in PPD were statistically significantly greater in the FV supplement group relative to the placebo group (</offsets><italic><offsets xml_i="43301" xml_f="43302" txt_i="29404" txt_f="29405">p</offsets></italic><offsets xml_i="43311" xml_f="43323" txt_i="29405" txt_f="29414"> &lt; 0.03; </offsets><xref ref-type="fig" rid="fig03"><offsets xml_i="43356" xml_f="43363" txt_i="29414" txt_f="29421">Fig. 3b</offsets></xref><offsets xml_i="43370" xml_f="43414" txt_i="29421" txt_f="29465">). This was not the case for the FVB group (</offsets><italic><offsets xml_i="43422" xml_f="43423" txt_i="29465" txt_f="29466">p</offsets></italic><offsets xml_i="43432" xml_f="43440" txt_i="29466" txt_f="29474"> = 0.7; </offsets><xref ref-type="fig" rid="fig03"><offsets xml_i="43473" xml_f="43480" txt_i="29474" txt_f="29481">Fig. 3b</offsets></xref><offsets xml_i="43487" xml_f="43688" txt_i="29481" txt_f="29682">). Although the PPD levels in the FV group remained lower than the placebo and FVB groups at 5- and 8-month recalls, differences were no longer statistically significant at these secondary time points.</offsets></p><p><offsets xml_i="43695" xml_f="43777" txt_i="29683" txt_f="29765">Significant post-treatment CAL gains were detected at all time points in both FV (</offsets><italic><offsets xml_i="43785" xml_f="43786" txt_i="29765" txt_f="29766">p</offsets></italic><offsets xml_i="43795" xml_f="43816" txt_i="29766" txt_f="29784"> &lt; 0.05) and FVB (</offsets><italic><offsets xml_i="43824" xml_f="43825" txt_i="29784" txt_f="29785">p</offsets></italic><offsets xml_i="43834" xml_f="43865" txt_i="29785" txt_f="29813"> &lt; 0.02) supplement groups (</offsets><xref ref-type="fig" rid="fig03"><offsets xml_i="43898" xml_f="43905" txt_i="29813" txt_f="29820">Fig. 3c</offsets></xref><offsets xml_i="43912" xml_f="44139" txt_i="29820" txt_f="30047">). In contrast, CAL gains in the placebo groups were only significant over baseline at 5 months. Despite this, CAL gains within supplement groups over those measured in the placebo group did not reach statistical significance (</offsets><italic><offsets xml_i="44147" xml_f="44148" txt_i="30047" txt_f="30048">p</offsets></italic><offsets xml_i="44157" xml_f="44169" txt_i="30048" txt_f="30057"> &gt; 0.09).</offsets></p><p><offsets xml_i="44176" xml_f="44259" txt_i="30058" txt_f="30141">At all post-treatment reviews, the percentage of sites bleeding on probing (% BOP; </offsets><xref ref-type="fig" rid="fig03"><offsets xml_i="44292" xml_f="44299" txt_i="30141" txt_f="30148">Fig. 3d</offsets></xref><offsets xml_i="44306" xml_f="44361" txt_i="30148" txt_f="30203">) was significantly reduced in all three study groups (</offsets><italic><offsets xml_i="44369" xml_f="44370" txt_i="30203" txt_f="30204">p</offsets></italic><offsets xml_i="44379" xml_f="44620" txt_i="30204" txt_f="30442"> &lt; 0.002). Although the reduction in % BOP was greatest at all time points for the supplement groups, the additional improvement relative to placebo was only statistically significant at the 5-month secondary time point for the FV group (</offsets><italic><offsets xml_i="44628" xml_f="44629" txt_i="30442" txt_f="30443">p</offsets></italic><offsets xml_i="44638" xml_f="44650" txt_i="30443" txt_f="30452"> &lt; 0.05).</offsets></p></sec><sec><title><offsets xml_i="44672" xml_f="44701" txt_i="30454" txt_f="30483">Changes in secondary outcomes</offsets></title><p><offsets xml_i="44712" xml_f="44787" txt_i="30484" txt_f="30559">Secondary outcomes, pre- and post-treatment completion, are illustrated in </offsets><xref ref-type="fig" rid="fig04"><offsets xml_i="44820" xml_f="44826" txt_i="30559" txt_f="30565">Fig. 4</offsets></xref><offsets xml_i="44833" xml_f="44865" txt_i="30565" txt_f="30597"> (and mean values documented in </offsets><xref ref-type="supplementary-material" rid="SD2"><offsets xml_i="44915" xml_f="44923" txt_i="30597" txt_f="30605">Table S2</offsets></xref><offsets xml_i="44930" xml_f="44932" txt_i="30605" txt_f="30607">).</offsets></p><fig id="fig04" position="float"><label><offsets xml_i="44976" xml_f="44982" txt_i="30608" txt_f="30614">Fig. 4</offsets></label><caption><p><offsets xml_i="45002" xml_f="45339" txt_i="30614" txt_f="30951">Changes in secondary outcomes during the study period (mean ± SD). (a) Gingival crevicular fluid (GCF) volumes (μl) – shallow sites; (b) GCF volume (μl) – deep sites; (c) cumulative plaque index; (d) recession (mm); (e) Gingival redness (MGI). Bars represent comparisons with baseline. Symbols alone represent comparisons with placebo. *</offsets><italic><offsets xml_i="45347" xml_f="45348" txt_i="30951" txt_f="30952">p</offsets></italic><offsets xml_i="45357" xml_f="45372" txt_i="30952" txt_f="30964"> &lt; 0.0001; ‡</offsets><italic><offsets xml_i="45380" xml_f="45381" txt_i="30964" txt_f="30965">p</offsets></italic><offsets xml_i="45390" xml_f="45404" txt_i="30965" txt_f="30976"> &lt; 0.007; ▪</offsets><italic><offsets xml_i="45412" xml_f="45413" txt_i="30976" txt_f="30977">p</offsets></italic><offsets xml_i="45422" xml_f="45436" txt_i="30977" txt_f="30988"> &lt; 0.005; ≠</offsets><italic><offsets xml_i="45444" xml_f="45445" txt_i="30988" txt_f="30989">p</offsets></italic><offsets xml_i="45454" xml_f="45468" txt_i="30989" txt_f="31000"> &lt; 0.002; •</offsets><italic><offsets xml_i="45476" xml_f="45477" txt_i="31000" txt_f="31001">p</offsets></italic><offsets xml_i="45486" xml_f="45500" txt_i="31001" txt_f="31012"> &lt; 0.01; □ </offsets><italic><offsets xml_i="45508" xml_f="45509" txt_i="31012" txt_f="31013">p</offsets></italic><offsets xml_i="45518" xml_f="45531" txt_i="31013" txt_f="31023"> &lt; 0.02; +</offsets><italic><offsets xml_i="45539" xml_f="45540" txt_i="31023" txt_f="31024">p</offsets></italic><offsets xml_i="45549" xml_f="45562" txt_i="31024" txt_f="31034"> &lt; 0.03; ♦</offsets><italic><offsets xml_i="45570" xml_f="45571" txt_i="31034" txt_f="31035">p</offsets></italic><offsets xml_i="45580" xml_f="45593" txt_i="31035" txt_f="31045"> &lt; 0.05; $</offsets><italic><offsets xml_i="45601" xml_f="45602" txt_i="31045" txt_f="31046">p</offsets></italic><offsets xml_i="45611" xml_f="45623" txt_i="31046" txt_f="31055"> &lt; 0.001.</offsets></p></caption><graphic xlink:href="jcpe0039-0062-f4"></graphic></fig><p><offsets xml_i="45695" xml_f="45792" txt_i="31056" txt_f="31153">Gingival crevicular fluid volumes at both shallow and deep sites reduced with time post-therapy (</offsets><xref ref-type="fig" rid="fig04"><offsets xml_i="45825" xml_f="45838" txt_i="31153" txt_f="31166">Fig. 4a and b</offsets></xref><offsets xml_i="45845" xml_f="45975" txt_i="31166" txt_f="31296">). Reductions in volume at shallow sites were small and changes only reached statistical significance at 8 months in the placebo (</offsets><italic><offsets xml_i="45983" xml_f="45984" txt_i="31296" txt_f="31297">p</offsets></italic><offsets xml_i="45993" xml_f="46012" txt_i="31297" txt_f="31316"> = 0.007) and FVB (</offsets><italic><offsets xml_i="46020" xml_f="46021" txt_i="31316" txt_f="31317">p</offsets></italic><offsets xml_i="46030" xml_f="46317" txt_i="31317" txt_f="31601"> &lt; 0.02) groups, with supplementation having no effect different to that shown by the placebo group. In contrast, GCF volumes at deep sites were significantly reduced at all time points in all groups post-therapy, with reductions being consistently greater in supplementation groups (</offsets><italic><offsets xml_i="46325" xml_f="46326" txt_i="31601" txt_f="31602">p</offsets></italic><offsets xml_i="46335" xml_f="46348" txt_i="31602" txt_f="31612"> &lt; 0.002; </offsets><xref ref-type="fig" rid="fig04"><offsets xml_i="46381" xml_f="46388" txt_i="31612" txt_f="31619">Fig. 4b</offsets></xref><offsets xml_i="46395" xml_f="46534" txt_i="31619" txt_f="31758">). However, the greater effect of supplementation on reducing GCF volume at deep sites was only significant at 2 months for the FVB group (</offsets><italic><offsets xml_i="46542" xml_f="46543" txt_i="31758" txt_f="31759">p</offsets></italic><offsets xml_i="46552" xml_f="46564" txt_i="31759" txt_f="31768"> &lt; 0.05).</offsets></p><p><offsets xml_i="46571" xml_f="46683" txt_i="31769" txt_f="31881">Significant reductions in cumulative plaque scores were detected at all time points post-therapy in all groups (</offsets><xref ref-type="fig" rid="fig04"><offsets xml_i="46716" xml_f="46723" txt_i="31881" txt_f="31888">Fig. 4c</offsets></xref><offsets xml_i="46730" xml_f="46732" txt_i="31888" txt_f="31890">; </offsets><italic><offsets xml_i="46740" xml_f="46741" txt_i="31890" txt_f="31891">p</offsets></italic><offsets xml_i="46750" xml_f="46921" txt_i="31891" txt_f="32059"> &lt; 0.03). No differences were evident between groups until month 8, when the reduction in plaque scores relative to baseline were significantly higher in the FV group (</offsets><italic><offsets xml_i="46929" xml_f="46930" txt_i="32059" txt_f="32060">p</offsets></italic><offsets xml_i="46939" xml_f="46983" txt_i="32060" txt_f="32101"> &lt; 0.05) compared with the placebo group.</offsets></p><p><offsets xml_i="46990" xml_f="47087" txt_i="32102" txt_f="32199">There were progressive improvements in recession and MGI post-therapy in all three study groups (</offsets><xref ref-type="fig" rid="fig04"><offsets xml_i="47120" xml_f="47133" txt_i="32199" txt_f="32212">Fig. 4d and e</offsets></xref><offsets xml_i="47140" xml_f="47142" txt_i="32212" txt_f="32214">; </offsets><italic><offsets xml_i="47150" xml_f="47151" txt_i="32214" txt_f="32215">p</offsets></italic><offsets xml_i="47160" xml_f="47270" txt_i="32215" txt_f="32322"> &lt; 0.001), but no significant differences in the magnitude of improvement between groups at any time point.</offsets></p></sec></sec><sec><title><offsets xml_i="47298" xml_f="47308" txt_i="32325" txt_f="32335">Discussion</offsets></title><p><offsets xml_i="47319" xml_f="48080" txt_i="32336" txt_f="33097">The current study is the first to report the impact of providing periodontitis patients with an adjunctive phytonutrient supplement during standard mechanical non-surgical periodontal therapy. We hypothesized that additional clinical benefit would result from supplementation with a juice powder concentrate (FV) and that the triple therapy (FVB) would provide enhanced outcomes over the dual supplement (FV) due to additional polyphenolic antioxidants. The rationale for such hypotheses was based upon the substantial literature base concerning the efficacy of antioxidant micronutrients in reducing extracellular oxidative stress, and their intracellular role in the down-regulation of redox-regulated pro-inflammatory gene transcription factors (reviewed by </offsets><xref ref-type="bibr" rid="b14"><offsets xml_i="48112" xml_f="48139" txt_i="33097" txt_f="33120">Chapple &amp; Matthews 2007</offsets></xref><offsets xml_i="48146" xml_f="48148" txt_i="33120" txt_f="33122">, </offsets><xref ref-type="bibr" rid="b9"><offsets xml_i="48179" xml_f="48191" txt_i="33122" txt_f="33134">Chapple 2009</offsets></xref><offsets xml_i="48198" xml_f="48769" txt_i="33134" txt_f="33705">). Statistically significant additional reductions in PPD were seen at the 2-month post-therapy recall visit for FV verses placebo, providing partial fulfilment of the first hypothesis. Therapy employing the FVB supplement did not, however, provide significantly improved primary outcomes relative to the placebo group, despite the presence of additional polyphenolic micronutrients within. Hypothesis two was therefore not fulfilled and nor was hypothesis three, as the initially greater pocket depth reduction in the FV group was not sustained at 8 months post-therapy.</offsets></p><p><offsets xml_i="48776" xml_f="49003" txt_i="33706" txt_f="33933">It was surprising not to see similar additional improvements for the FVB as the FV group, but this may be explained by the reduced bioavailability of micronutrients in this group as demonstrated by the serum β-carotene levels (</offsets><xref ref-type="fig" rid="fig02"><offsets xml_i="49036" xml_f="49042" txt_i="33933" txt_f="33939">Fig. 2</offsets></xref><offsets xml_i="49049" xml_f="49211" txt_i="33939" txt_f="34101">). It may also be explained by nutrigenetic differences between groups, as polymorphisms in the BCMO1 gene (β-carotene 15,15′-monoxygenase) have been identified (</offsets><xref ref-type="bibr" rid="b33"><offsets xml_i="49243" xml_f="49260" txt_i="34101" txt_f="34118">Leung et al. 2009</offsets></xref><offsets xml_i="49267" xml_f="50059" txt_i="34118" txt_f="34910">) which appear to explain, at least in part, the low conversion rates of β-carotene to its bioactive form in many individuals. The attenuation in serum β-carotene concentrations at 5 and 8 months could also have arisen due to reduced adherence to supplementation in the FVB group; however, this thesis was not supported by the supplement diary and capsule count analysis. An alternative explanation is that micronutrient absorption across the gastrointestinal tract wall may have been lower in the FVB than the FV group, or that the additional polyphenolic compounds within the FVB supplement antagonized beneficial activities of other components. Whatever the explanation, the plasma β-carotene data demonstrate reduced bioavailability of some micronutrients in the FVB group relative to FV.</offsets></p><p><offsets xml_i="50066" xml_f="51181" txt_i="34911" txt_f="36026">Significant additional reductions in percentage sites bleeding on probing arose for the FV group at 5 months (following the increased 2-month pocket depth reductions). The cumulative plaque index data recorded in the supplementation group are also interesting, as significant additional decreases were observed at the 8-month follow-up visit for FV verses placebo, 3 months after the additional improvements in percentage sites bleeding recorded in the same group (FV). Although it could be argued that the improved plaque index in the supplement group arose due to better home care/compliance, this seems unlikely, as there were no differences between groups in plaque indices at 2- and 5-month recalls, where the most substantial reductions in plaque took place. An alternative and intriguing explanation is that additional reductions in inflammation evident at 5 months were reflected in the composition of the GCF, which in turn led to a reduced biofilm accumulation. Although this is consistent with current evidence that the inflammatory status of the gingival tissues influences plaque biofilm accumulation (</offsets><xref ref-type="bibr" rid="b23"><offsets xml_i="51213" xml_f="51235" txt_i="36026" txt_f="36044">Hillam &amp; Hull 1977</offsets></xref><offsets xml_i="51242" xml_f="51244" txt_i="36044" txt_f="36046">, </offsets><xref ref-type="bibr" rid="b3"><offsets xml_i="51275" xml_f="51298" txt_i="36046" txt_f="36069">Baumgartner et al. 2009</offsets></xref><offsets xml_i="51305" xml_f="51386" txt_i="36069" txt_f="36150">) and with current consensus views on host response/biofilm inter-relationships (</offsets><xref ref-type="bibr" rid="b54"><offsets xml_i="51418" xml_f="51444" txt_i="36150" txt_f="36172">Tonetti &amp; Chapple 2011</offsets></xref><offsets xml_i="51451" xml_f="51842" txt_i="36172" txt_f="36563">), plaque re-growth studies and those analysing GCF composition would be necessary to substantiate such a thesis. A prebiotic effect upon biofilm accumulation is unlikely as capsules were swallowed and nutrients not applied locally. Any effect therefore would appear likely to be due to the influence of an altered systemic (and downstream local) host response upon the periodontal biofilm (</offsets><xref ref-type="bibr" rid="b37"><offsets xml_i="51874" xml_f="51897" txt_i="36563" txt_f="36582">Marsh &amp; Devine 2011</offsets></xref><offsets xml_i="51904" xml_f="51906" txt_i="36582" txt_f="36584">).</offsets></p><p><offsets xml_i="51913" xml_f="52079" txt_i="36585" txt_f="36751">The healing and resolution of inflammation arising from the non-surgical mechanical therapy alone (placebo group) was substantial and consistent with the literature (</offsets><xref ref-type="bibr" rid="b58"><offsets xml_i="52111" xml_f="52148" txt_i="36751" txt_f="36784">van der Weijden &amp; Timmermann 2002</offsets></xref><offsets xml_i="52155" xml_f="52488" txt_i="36784" txt_f="37117">), with clinically significant increases in the number of closed pockets apparent at 2 months and at subsequent recalls. Moreover, there were no baseline differences between groups in circulating concentrations of vitamin E, vitamin C or β-carotene, all of which were within or close to the low end of published SI reference ranges (</offsets><xref ref-type="bibr" rid="b60"><offsets xml_i="52520" xml_f="52530" txt_i="37117" txt_f="37127">Young 1987</offsets></xref><offsets xml_i="52537" xml_f="52983" txt_i="37127" txt_f="37573">). Taken together, it is perhaps surprising that any additional clinical benefit was achieved in patients who were effectively nutritionally replete and in whom non-surgical management alone was highly successful. Some of those benefits were not retained after 8 months, a finding that does not fulfil our third hypothesis and which may be explained by a number of factors, including a tendency for recalcitrant disease to develop at this stage (</offsets><xref ref-type="bibr" rid="b46"><offsets xml_i="53015" xml_f="53035" txt_i="37573" txt_f="37593">Quirynen et al. 2005</offsets></xref><offsets xml_i="53042" xml_f="53201" txt_i="37593" txt_f="37752">). However, given that there is a more limited rationale to the expectation of improved therapeutic outcomes in nutritionally replete verses deplete patients (</offsets><xref ref-type="bibr" rid="b48"><offsets xml_i="53233" xml_f="53248" txt_i="37752" txt_f="37767">Schifferle 2009</offsets></xref><offsets xml_i="53255" xml_f="53706" txt_i="37767" txt_f="38218">) and that non-surgical therapy was successful without adjunctive nutritional support, it is possible that more substantial clinical benefits may be realized from such dietary augmentation in nutritionally depleted periodontitis patients or in those who do not have access to dental services for periodontal therapy. The public health benefits of such an approach, in a society where obesity trends are increasing and diets are decreasing in quality (</offsets><xref ref-type="bibr" rid="b25"><offsets xml_i="53738" xml_f="53757" txt_i="38218" txt_f="38237">Jenzsch et al. 2009</offsets></xref><offsets xml_i="53764" xml_f="53980" txt_i="38237" txt_f="38453">) may be substantial if proven. Indeed, there is evidence from one intervention study in patients with metabolic syndrome that inflammatory periodontal outcome measures improved following a nutritional intervention (</offsets><xref ref-type="bibr" rid="b25"><offsets xml_i="54012" xml_f="54031" txt_i="38453" txt_f="38472">Jenzsch et al. 2009</offsets></xref><offsets xml_i="54038" xml_f="54212" txt_i="38472" txt_f="38646">). Such findings when allied to the impact of periodontal inflammation upon systemic inflammatory status may further impact upon chronic inflammation in the body in general (</offsets><xref ref-type="bibr" rid="b29"><offsets xml_i="54244" xml_f="54265" txt_i="38646" txt_f="38667">Kawashima et al. 2007</offsets></xref><offsets xml_i="54272" xml_f="54274" txt_i="38667" txt_f="38669">, </offsets><xref ref-type="bibr" rid="b26"><offsets xml_i="54306" xml_f="54321" txt_i="38669" txt_f="38684">Jin et al. 2010</offsets></xref><offsets xml_i="54328" xml_f="54330" txt_i="38684" txt_f="38686">).</offsets></p><p><offsets xml_i="54337" xml_f="55120" txt_i="38687" txt_f="39470">There are limitations to the current study. Firstly, the study may have lacked the power to detect the beneficial effects of FV and FVB because we had no prior data upon which to base sample size estimates. Secondly, assessing protocol adherence was difficult, preventing a “per protocol” analysis. The analysis presented is an “ITT” analysis, which assumes that non-adherence will be random and thus equitable across the three groups. We did not attempt to ascertain nutrigenetic parameters which are likely to dictate “high responders” and “low responders”, largely because this science is in its infancy and the most appropriate outcome measures are unknown, with the exception of recent discoveries in relation to β-carotene converter status and polymorphisms in the BCMO1 gene (</offsets><xref ref-type="bibr" rid="b33"><offsets xml_i="55152" xml_f="55169" txt_i="39470" txt_f="39487">Leung et al. 2009</offsets></xref><offsets xml_i="55176" xml_f="55386" txt_i="39487" txt_f="39697">). Thirdly, the high improvements recorded in the placebo group from mechanical debridement alone are likely to have created a ceiling effect, whereby further improvement from adjunctive therapy is less likely.</offsets></p><p><offsets xml_i="55393" xml_f="56417" txt_i="39698" txt_f="40722">We conclude that adjunctive daily supplementation with an encapsulated FV juice powder concentrate, during non-surgical periodontal therapy, appears to offer additional initial pocket depth reductions, and subsequent additional improvements in bleeding on probing and plaque scores even in high responders to conventional therapy and in those who are not nutritionally compromised. However, outcomes seem to depend upon the serum/plasma micronutrient concentrations achieved, and this requires patient adherence and likely favourable absorption across the gastrointestinal tract wall. Further studies are necessary to assess such approaches in larger and more diverse populations, employing different supplement and therapeutic regimes. In particular, monotherapy studies (phytonutrient supplementation alone) and studies in nutritionally compromised patients are necessary to help build a clearer picture of the clinical impact of antioxidant phytonutrient supplementation upon periodontal and systemic inflammatory status.</offsets></p></sec></body><back><ref-list><title>References</title><ref id="b1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaliya</surname></name><name><surname>Timmermann</surname><given-names>MF</given-names></name><name><surname>Abbas</surname><given-names>F</given-names></name><name><surname>Loos</surname><given-names>BG</given-names></name><name><surname>van der Weijden</surname><given-names>GA</given-names></name><name><surname>van Winkelhoff</surname><given-names>AJ</given-names></name><name><surname>Winkel</surname><given-names>EG</given-names></name><name><surname>van der Velden</surname><given-names>U</given-names></name></person-group><article-title>Java project on periodontal diseases: the relationship between vitamin C and the severity of periodontitis</article-title><source>Journal of Clinical Periodontology</source><year>2007</year><volume>34</volume><fpage>299</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">17378886</pub-id></element-citation></ref><ref id="b2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amarasena</surname><given-names>N</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Yoshihara</surname><given-names>A</given-names></name><name><surname>Hanada</surname><given-names>N</given-names></name><name><surname>Miyazaki</surname><given-names>H</given-names></name></person-group><article-title>Serum vitamin C-periodontal relationship in community-dwelling elderly Japanese</article-title><source>Journal of Clinical Periodontology</source><year>2005</year><volume>32</volume><fpage>93</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">15642065</pub-id></element-citation></ref><ref id="b3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgartner</surname><given-names>S</given-names></name><name><surname>Imfeld</surname><given-names>T</given-names></name><name><surname>Schicht</surname><given-names>O</given-names></name><name><surname>Rath</surname><given-names>C</given-names></name><name><surname>Persson</surname><given-names>RE</given-names></name><name><surname>Persson</surname><given-names>GR</given-names></name></person-group><article-title>The impact of the Stone Age diet on gingival conditions in the absence of oral hygiene</article-title><source>Journal of Periodontology</source><year>2009</year><volume>80</volume><fpage>759</fpage><lpage>768</lpage><pub-id pub-id-type="pmid">19405829</pub-id></element-citation></ref><ref id="b4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bawadi</surname><given-names>HA</given-names></name><name><surname>Khader</surname><given-names>YS</given-names></name><name><surname>Haroun</surname><given-names>TF</given-names></name><name><surname>Al-Omar</surname><given-names>M</given-names></name><name><surname>Tayyem</surname><given-names>RF</given-names></name></person-group><article-title>The association between periodontal disease, physical activity and healthy diet among adults in Jordan</article-title><source>Journal of Periodontal Research</source><year>2011</year><volume>46</volume><fpage>74</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">20860591</pub-id></element-citation></ref><ref id="b5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brock</surname><given-names>GR</given-names></name><name><surname>Butterworth</surname><given-names>CJ</given-names></name><name><surname>Matthews</surname><given-names>JB</given-names></name><name><surname>Chapple</surname><given-names>IL</given-names></name></person-group><article-title>Local and systemic total antioxidant capacity in periodontitis and health</article-title><source>Journal of Clinical Periodontology</source><year>2004</year><volume>31</volume><fpage>515</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">15191586</pub-id></element-citation></ref><ref id="b6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullon</surname><given-names>P</given-names></name><name><surname>Morillo</surname><given-names>M</given-names></name><name><surname>Ramirez-Tortosa</surname><given-names>MC</given-names></name><name><surname>Quiles</surname><given-names>JL</given-names></name><name><surname>Newman</surname><given-names>HN</given-names></name><name><surname>Battino</surname><given-names>M</given-names></name></person-group><article-title>Metabolic syndrome and periodontitis: is oxidative stress a common link?</article-title><source>Journal of Dental Research</source><year>2009</year><volume>88</volume><fpage>503</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">19587154</pub-id></element-citation></ref><ref id="b7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceriello</surname><given-names>A</given-names></name><name><surname>Esposito</surname><given-names>K</given-names></name><name><surname>Piconi</surname><given-names>L</given-names></name><name><surname>Ihnat</surname><given-names>MA</given-names></name><name><surname>Thorpe</surname><given-names>JE</given-names></name><name><surname>Testa</surname><given-names>R</given-names></name><name><surname>Boemi</surname><given-names>M</given-names></name><name><surname>Giugliano</surname><given-names>D</given-names></name></person-group><article-title>Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><fpage>1349</fpage><lpage>1354</lpage><pub-id pub-id-type="pmid">18299315</pub-id></element-citation></ref><ref id="b8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapple</surname><given-names>ILC</given-names></name><name><surname>Milward</surname><given-names>MR</given-names></name><name><surname>Dietrich</surname><given-names>T</given-names></name></person-group><article-title>The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations</article-title><source>Journal of Nutrition</source><year>2007a</year><volume>137</volume><fpage>657</fpage><lpage>664</lpage><pub-id pub-id-type="pmid">17311956</pub-id></element-citation></ref><ref id="b9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapple</surname><given-names>ILC</given-names></name></person-group><article-title>Potential mechanisms underpinning the nutritional modulation of periodontal inflammation</article-title><source>Journal of the American Dental Association</source><year>2009</year><volume>1402</volume><fpage>178</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">19188414</pub-id></element-citation></ref><ref id="b10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapple</surname><given-names>ILC</given-names></name><name><surname>Brock</surname><given-names>G</given-names></name><name><surname>Eftimiadi</surname><given-names>C</given-names></name><name><surname>Matthews</surname><given-names>JB</given-names></name></person-group><article-title>Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease</article-title><source>Journal of Clinical Pathology: Molecular Pathology</source><year>2002</year><volume>55</volume><fpage>367</fpage><lpage>373</lpage></element-citation></ref><ref id="b11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapple</surname><given-names>ILC</given-names></name><name><surname>Brock</surname><given-names>GR</given-names></name><name><surname>Milward</surname><given-names>MR</given-names></name><name><surname>Ling</surname><given-names>N</given-names></name><name><surname>Matthews</surname><given-names>JB</given-names></name></person-group><article-title>Compromised GCF total antioxidant capacity in periodontitis: cause or effect?</article-title><source>Journal of Clinical Periodontology</source><year>2007b</year><volume>34</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">17214737</pub-id></element-citation></ref><ref id="b12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapple</surname><given-names>ILC</given-names></name><name><surname>Landini</surname><given-names>G</given-names></name><name><surname>Griffiths</surname><given-names>GS</given-names></name><name><surname>Patel</surname><given-names>NC</given-names></name><name><surname>Ward</surname><given-names>RSN</given-names></name></person-group><article-title>Calibration of the Periotron 8000® and 6000® by polynomial regression</article-title><source>Journal of Periodontal Research</source><year>1999</year><volume>34</volume><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">10207836</pub-id></element-citation></ref><ref id="b13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapple</surname><given-names>ILC</given-names></name><name><surname>Mason</surname><given-names>GM</given-names></name><name><surname>Matthews</surname><given-names>JB</given-names></name><name><surname>Thorpe</surname><given-names>GHG</given-names></name><name><surname>Maxwell</surname><given-names>SRJ</given-names></name><name><surname>Whitehead</surname><given-names>T</given-names></name></person-group><article-title>Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid</article-title><source>Annals of Clinical Biochemistry</source><year>1997</year><volume>34</volume><fpage>412</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">9247675</pub-id></element-citation></ref><ref id="b14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapple</surname><given-names>ILC</given-names></name><name><surname>Matthews</surname><given-names>JB</given-names></name></person-group><article-title>The role of reactive oxygen and antioxidant species in periodontal tissue destruction</article-title><source>Periodontology</source><year>2007</year><volume>2000</volume><issue>43</issue><fpage>160</fpage><lpage>232</lpage></element-citation></ref><ref id="b15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobb</surname><given-names>CM</given-names></name></person-group><article-title>Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing</article-title><source>Journal of Clinical Periodontology</source><year>2002</year><volume>29</volume><issue>Suppl. 2</issue><fpage>6</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">12010523</pub-id></element-citation></ref><ref id="b16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Aiuto</surname><given-names>F</given-names></name><name><surname>Nibali</surname><given-names>L</given-names></name><name><surname>Parkar</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>K</given-names></name><name><surname>Suvan</surname><given-names>J</given-names></name><name><surname>Donos</surname><given-names>N</given-names></name></person-group><article-title>Oxidative stress, systemic inflammation and severe periodontitis</article-title><source>Journal of Dental Research</source><year>2010</year><volume>89</volume><fpage>1241</fpage><lpage>1246</lpage><pub-id pub-id-type="pmid">20739696</pub-id></element-citation></ref><ref id="b17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Aiuto</surname><given-names>F</given-names></name><name><surname>Parkar</surname><given-names>M</given-names></name><name><surname>Andreou</surname><given-names>G</given-names></name><name><surname>Suvan</surname><given-names>J</given-names></name><name><surname>Brett</surname><given-names>PM</given-names></name><name><surname>Ready</surname><given-names>D</given-names></name><name><surname>Tonetti</surname><given-names>MS</given-names></name></person-group><article-title>Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers</article-title><source>Journal of Dental Research</source><year>2004b</year><volume>83</volume><fpage>156</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">14742655</pub-id></element-citation></ref><ref id="b18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Aiuto</surname><given-names>F</given-names></name><name><surname>Ready</surname><given-names>D</given-names></name><name><surname>Tonetti</surname><given-names>MS</given-names></name></person-group><article-title>Periodontal disease and C-reactive protein-associated cardiovascular risk</article-title><source>Journal of Periodontal Research</source><year>2004a</year><volume>39</volume><fpage>236</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">15206916</pub-id></element-citation></ref><ref id="b19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enwonwu</surname><given-names>CO</given-names></name><name><surname>Philips</surname><given-names>RS</given-names></name><name><surname>Falkler</surname><given-names>WA</given-names><suffix>Jr</suffix></name></person-group><article-title>Nutrition and oral infectious diseases: state of the science</article-title><source>Compendium of continuing dental education</source><year>2002</year><volume>23</volume><fpage>431</fpage><lpage>448</lpage></element-citation></ref><ref id="b20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>K</given-names></name><name><surname>Ciotola</surname><given-names>M</given-names></name><name><surname>Carleo</surname><given-names>D</given-names></name><name><surname>Schisano</surname><given-names>B</given-names></name><name><surname>Sardelli</surname><given-names>L</given-names></name><name><surname>Di Tommaso</surname><given-names>D</given-names></name><name><surname>Misso</surname><given-names>L</given-names></name><name><surname>Saccomanno</surname><given-names>F</given-names></name><name><surname>Ceriello</surname><given-names>A</given-names></name><name><surname>Giugliano</surname><given-names>D</given-names></name></person-group><article-title>Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><year>2008</year><volume>93</volume><fpage>1345</fpage><lpage>1350</lpage><pub-id pub-id-type="pmid">18198229</pub-id></element-citation></ref><ref id="b21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galli</surname><given-names>C</given-names></name><name><surname>Passeri</surname><given-names>G</given-names></name><name><surname>Macaluso</surname><given-names>GM</given-names></name></person-group><article-title>FoxOs, Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena ?</article-title><source>Journal of Periodontal Research</source><year>2011</year><volume>46</volume><fpage>397</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">21332475</pub-id></element-citation></ref><ref id="b22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>MM</given-names></name><name><surname>Brock</surname><given-names>GR</given-names></name><name><surname>Matthews</surname><given-names>JB</given-names></name><name><surname>Chapple</surname><given-names>ILC</given-names></name></person-group><article-title>Crevicular fluid glutathione levels in periodontitis and the effect of non-surgical therapy</article-title><source>Journal of Clinical Periodontology</source><year>2010</year><volume>37</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">19968740</pub-id></element-citation></ref><ref id="b23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillam</surname><given-names>DG</given-names></name><name><surname>Hull</surname><given-names>PS</given-names></name></person-group><article-title>The influence of experimental gingivitis upon plaque formation</article-title><source>Journal of Clinical Periodontology</source><year>1977</year><volume>4</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">321485</pub-id></element-citation></ref><ref id="b24"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Iverson</surname><given-names>C</given-names></name><name><surname>Christiansen</surname><given-names>S</given-names></name><name><surname>Flanagin</surname><given-names>A</given-names></name><name><surname>Fontanarosa</surname><given-names>P</given-names></name><name><surname>Glass</surname><given-names>R</given-names></name><name><surname>Gregoline</surname><given-names>B</given-names></name><name><surname>Lurie</surname><given-names>SJ</given-names></name><name><surname>Meyer</surname><given-names>HS</given-names></name><name><surname>Winker</surname><given-names>MA</given-names></name><name><surname>Young</surname><given-names>RK</given-names></name></person-group><source>AMA Manual of Style</source><year>2007</year><edition>10th edition</edition><publisher-loc>New York</publisher-loc><publisher-name>Oxford University Press; American Medical Association</publisher-name></element-citation></ref><ref id="b25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenzsch</surname><given-names>A</given-names></name><name><surname>Eick</surname><given-names>S</given-names></name><name><surname>Rassoul</surname><given-names>F</given-names></name><name><surname>Purschwitz</surname><given-names>R</given-names></name><name><surname>Jentsch</surname><given-names>H</given-names></name></person-group><article-title>Nutritional intervention in patients with periodontal disease: clinical, immunological and microbiological variables during 12 months</article-title><source>British Journal of Nutrition</source><year>2009</year><volume>101</volume><fpage>879</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">18713481</pub-id></element-citation></ref><ref id="b26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Singh</surname><given-names>UP</given-names></name><name><surname>Chumanevich</surname><given-names>AA</given-names></name><name><surname>Harmon</surname><given-names>B</given-names></name><name><surname>Cavicchia</surname><given-names>P</given-names></name><name><surname>Hofseth</surname><given-names>AB</given-names></name><name><surname>Kotakadi</surname><given-names>V</given-names></name><name><surname>Stroud</surname><given-names>B</given-names></name><name><surname>Volate</surname><given-names>SR</given-names></name><name><surname>Hurley</surname><given-names>TG</given-names></name><name><surname>Hebert</surname><given-names>JR</given-names></name><name><surname>Hofseth</surname><given-names>LJ</given-names></name></person-group><article-title>Systemic inflammatory load in humans is suppressed by consumption of two formulations of dried, encapsulated juice concentrate</article-title><source>Molecular Nutrition Food Research</source><year>2010</year><volume>54</volume><fpage>1506</fpage><lpage>1514</lpage><pub-id pub-id-type="pmid">20425759</pub-id></element-citation></ref><ref id="b27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshipura</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Speizer</surname><given-names>FE</given-names></name><name><surname>Colditz</surname><given-names>G</given-names></name><name><surname>Ascherio</surname><given-names>A</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>The effect of fruit and vegetable intake on risk for coronary heart disease</article-title><source>Annals of Internal Medicine</source><year>2001</year><volume>134</volume><fpage>1106</fpage><lpage>1114</lpage><pub-id pub-id-type="pmid">11412050</pub-id></element-citation></ref><ref id="b28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshipura</surname><given-names>KJ</given-names></name><name><surname>Ascherio</surname><given-names>A</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Speizer</surname><given-names>FE</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name><name><surname>Spiegleman</surname><given-names>D</given-names></name><name><surname>Willet</surname><given-names>WC</given-names></name></person-group><article-title>Fruit and vegetable intake in relation to risk of ischaemic stroke</article-title><source>Journal of the American Medical Association</source><year>1999</year><volume>282</volume><fpage>1233</fpage><lpage>1239</lpage><pub-id pub-id-type="pmid">10517425</pub-id></element-citation></ref><ref id="b29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawashima</surname><given-names>A</given-names></name><name><surname>Madarame</surname><given-names>T</given-names></name><name><surname>Koike</surname><given-names>H</given-names></name><name><surname>Komatsu</surname><given-names>Y</given-names></name><name><surname>Wise</surname><given-names>JA</given-names></name></person-group><article-title>Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects</article-title><source>Asia Pacific Journal of Clinical Nutrition</source><year>2007</year><volume>16</volume><fpage>411</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">17704021</pub-id></element-citation></ref><ref id="b30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Jarvinen</surname><given-names>R</given-names></name><name><surname>Reunanen</surname><given-names>A</given-names></name><name><surname>Maatela</surname><given-names>J</given-names></name></person-group><article-title>Flavonoid intake and coronary mortality in Finland: a cohort study</article-title><source>British Medical Journal</source><year>1996</year><volume>312</volume><fpage>478</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">8597679</pub-id></element-citation></ref><ref id="b31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>König</surname><given-names>J</given-names></name><name><surname>Holtfreter</surname><given-names>B</given-names></name><name><surname>Kocher</surname><given-names>T</given-names></name></person-group><article-title>Periodontal health in Europe: future trends based on treatment needs and the provision of periodontal services – position paper 1</article-title><source>European Journal of Dental Education</source><year>2010</year><volume>14</volume><issue>suppl 1</issue><fpage>4</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">20415972</pub-id></element-citation></ref><ref id="b32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konopka</surname><given-names>T</given-names></name><name><surname>Król</surname><given-names>K</given-names></name><name><surname>Kopeć</surname><given-names>W</given-names></name><name><surname>Gerber</surname><given-names>H</given-names></name></person-group><article-title>Total antioxidant status and 8-hydroxy-2′-deoxyguanosine levels in gingival and peripheral blood of periodontitis patients</article-title><source>Archivum Immunologiae et Therapiae Experimentalis (Warszawa)</source><year>2007</year><volume>55</volume><fpage>417</fpage><lpage>422</lpage></element-citation></ref><ref id="b33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>WC</given-names></name><name><surname>Hessel</surname><given-names>S</given-names></name><name><surname>Méplan</surname><given-names>C</given-names></name><name><surname>Flint</surname><given-names>J</given-names></name><name><surname>Oberhauser</surname><given-names>V</given-names></name><name><surname>Tourniaire</surname><given-names>F</given-names></name><name><surname>Hesketh</surname><given-names>JE</given-names></name><name><surname>von Lintig</surname><given-names>J</given-names></name><name><surname>Lietz</surname><given-names>G</given-names></name></person-group><article-title>Two common single nucleotide polymorphisms in the gene encoding β-carotene 15,15′ –monoxygenase alter β-carotene metabolism in female volunteers</article-title><source>The FASEB Journal</source><year>2009</year><volume>23</volume><fpage>1041</fpage><lpage>1053</lpage><pub-id pub-id-type="pmid">19103647</pub-id></element-citation></ref><ref id="b34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linden</surname><given-names>GJ</given-names></name><name><surname>McClean</surname><given-names>KM</given-names></name><name><surname>Woodside</surname><given-names>JV</given-names></name><name><surname>Patterson</surname><given-names>CC</given-names></name><name><surname>Evand</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>IS</given-names></name><name><surname>Kee</surname><given-names>F</given-names></name></person-group><article-title>Antioxidants and periodontitis in 60–70-year-old men</article-title><source>Journal of Clinical Periodontology</source><year>2009</year><volume>36</volume><fpage>843</fpage><lpage>849</lpage><pub-id pub-id-type="pmid">19703237</pub-id></element-citation></ref><ref id="b35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobene</surname><given-names>R</given-names></name><name><surname>Weatherford</surname><given-names>T</given-names></name><name><surname>Ross</surname><given-names>N</given-names></name><name><surname>Lamm</surname><given-names>R</given-names></name><name><surname>Menaker</surname><given-names>L</given-names></name></person-group><article-title>A modified gingival index for use in clinical trials</article-title><source>Clinical Preventive dentistry</source><year>1986</year><volume>8</volume><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="b36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobene</surname><given-names>RR</given-names></name><name><surname>Soparker</surname><given-names>PM</given-names></name><name><surname>Newman</surname><given-names>BS</given-names></name></person-group><article-title>Use of Dental Floss. Effect of plaque and gingivitis</article-title><source>Clinical Preventive Dentistry</source><year>1982</year><volume>4</volume><fpage>5</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">6980082</pub-id></element-citation></ref><ref id="b37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>PD</given-names></name><name><surname>Devine</surname><given-names>DA</given-names></name></person-group><article-title>How is the development of dental biofilms influenced by the host</article-title><source>Journal of Clinical Periodontology</source><year>2011</year><volume>38</volume><issue>s 11</issue><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">21323701</pub-id></element-citation></ref><ref id="b38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalowicz</surname><given-names>BS</given-names></name><name><surname>Aeppli</surname><given-names>D</given-names></name><name><surname>Virag</surname><given-names>JG</given-names></name><name><surname>Klump</surname><given-names>DG</given-names></name><name><surname>Hinrichs</surname><given-names>JE</given-names></name><name><surname>Segal</surname><given-names>NL</given-names></name><name><surname>Bouchard</surname><given-names>TJ</given-names><suffix>Jr</suffix></name><name><surname>Pihlstrom</surname><given-names>BL</given-names></name></person-group><article-title>Periodontal findings in adult twins</article-title><source>Journal of Periodontology</source><year>1991</year><volume>62</volume><fpage>293</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">2072240</pub-id></element-citation></ref><ref id="b39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monnier</surname><given-names>L</given-names></name><name><surname>Mas</surname><given-names>E</given-names></name><name><surname>Ginet</surname><given-names>E</given-names></name><name><surname>Michel</surname><given-names>F</given-names></name><name><surname>Villon</surname><given-names>L</given-names></name><name><surname>Cristol</surname><given-names>JP</given-names></name><name><surname>Colette</surname><given-names>C</given-names></name></person-group><article-title>Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes</article-title><source>Journal of the American Medical Association</source><year>2006</year><volume>295</volume><fpage>1681</fpage><lpage>1687</lpage><pub-id pub-id-type="pmid">16609090</pub-id></element-citation></ref><ref id="b40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishada</surname><given-names>M</given-names></name><name><surname>Grossi</surname><given-names>SG</given-names></name><name><surname>Dunford</surname><given-names>RG</given-names></name><name><surname>Ho</surname><given-names>AW</given-names></name><name><surname>Trevisan</surname><given-names>M</given-names></name><name><surname>Genco</surname><given-names>RJ</given-names></name></person-group><article-title>Dietary vitamin C and the risk for periodontal disease</article-title><source>Journal of Periodontology</source><year>2000</year><volume>71</volume><fpage>1215</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">10972636</pub-id></element-citation></ref><ref id="b41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Keefe</surname><given-names>J</given-names></name><name><surname>Bell</surname><given-names>D</given-names></name></person-group><article-title>Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor</article-title><source>American Journal of Cardiology</source><year>2007</year><volume>100</volume><fpage>899</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">17719342</pub-id></element-citation></ref><ref id="b42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Keefe</surname><given-names>JH</given-names></name><name><surname>Gheewala</surname><given-names>NM</given-names></name><name><surname>O'Keefe</surname><given-names>JO</given-names></name></person-group><article-title>Dietary strategies for improving postprandial glucose, lipids, inflammation, and cardiovascular health</article-title><source>Journal of the American College of Cardiology</source><year>2008</year><volume>51</volume><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">18206731</pub-id></element-citation></ref><ref id="b43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panjamurthy</surname><given-names>K</given-names></name><name><surname>Manoharan</surname><given-names>S</given-names></name><name><surname>Ramachandran</surname><given-names>CR</given-names></name></person-group><article-title>Lipid peroxidation and antioxidant status in patients with periodontitis</article-title><source>Cellular and Molecular Biology Letters</source><year>2005</year><volume>10</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">16010291</pub-id></element-citation></ref><ref id="b44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plotnick</surname><given-names>GD</given-names></name><name><surname>Corretti</surname><given-names>MC</given-names></name><name><surname>Vogel</surname><given-names>RA</given-names></name><name><surname>Hesslink</surname><given-names>R</given-names></name><name><surname>Wise</surname><given-names>JA</given-names></name></person-group><article-title>Effect of supplemental phytonutrients on impairment of the flow-mediated brachial vasoactivity after a single high fat meal</article-title><source>Journal of the American College of Cardiology</source><year>2003</year><volume>41</volume><fpage>1744</fpage><lpage>1749</lpage><pub-id pub-id-type="pmid">12767658</pub-id></element-citation></ref><ref id="b45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polidori</surname><given-names>MC</given-names></name><name><surname>Stahl</surname><given-names>W</given-names></name><name><surname>Eichler</surname><given-names>O</given-names></name><name><surname>Niestroj</surname><given-names>I</given-names></name><name><surname>Sies</surname><given-names>H</given-names></name></person-group><article-title>Profiles of antioxidants in human plasma</article-title><source>Free Radical Biology &amp; Medicine</source><year>2001</year><volume>30</volume><fpage>456</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">11182517</pub-id></element-citation></ref><ref id="b46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quirynen</surname><given-names>M</given-names></name><name><surname>Vogels</surname><given-names>R</given-names></name><name><surname>Pauwels</surname><given-names>M</given-names></name><name><surname>Haffajee</surname><given-names>AD</given-names></name><name><surname>Socransky</surname><given-names>SS</given-names></name><name><surname>Uzel</surname><given-names>NG</given-names></name><name><surname>van Steenberghe</surname><given-names>D</given-names></name></person-group><article-title>Initial subgingival colonization of ‘pristine’ pockets</article-title><source>Journal of Dental Research</source><year>2005</year><volume>84</volume><fpage>340</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">15790740</pub-id></element-citation></ref><ref id="b47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauvaget</surname><given-names>C</given-names></name><name><surname>Nagano</surname><given-names>J</given-names></name><name><surname>Hayashi</surname><given-names>M</given-names></name><name><surname>Spencer</surname><given-names>E</given-names></name><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Allen</surname><given-names>N</given-names></name></person-group><article-title>Vegetables and fruit intake and cancer mortality in the Hiroshima/Nagasaki Life Span Study</article-title><source>British Journal of Cancer</source><year>2003</year><volume>88</volume><fpage>689</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">12618875</pub-id></element-citation></ref><ref id="b48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schifferle</surname><given-names>RE</given-names></name></person-group><article-title>Periodontal disease and nutrition: separating the evidence from current fads</article-title><source>Periodontology</source><year>2009</year><volume>2000</volume><issue>50</issue><fpage>78</fpage><lpage>89</lpage></element-citation></ref><ref id="b49"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>D</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Fink</surname><given-names>G</given-names></name></person-group><article-title>Oxidative stress</article-title><source>Encyclopedia of Stress</source><year>2007</year><volume>3</volume><publisher-loc>Amsterdam</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>45</fpage><lpage>48</lpage></element-citation></ref><ref id="b50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H</given-names></name><name><surname>Stahl</surname><given-names>W</given-names></name><name><surname>Sevanian</surname><given-names>A</given-names></name></person-group><article-title>Nutritional, dietary and postprandial oxidative stress</article-title><source>Journal of Nutrition</source><year>2005</year><volume>135</volume><fpage>969</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">15867266</pub-id></element-citation></ref><ref id="b51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname><given-names>W</given-names></name><name><surname>Sundquist</surname><given-names>AR</given-names></name><name><surname>Hanusch</surname><given-names>M</given-names></name><name><surname>Schwarz</surname><given-names>W</given-names></name><name><surname>Sies</surname><given-names>H</given-names></name></person-group><article-title>Separation of beta-carotene and lycopene geometrical isomers in biological samples</article-title><source>Skin Research Technology</source><year>1993</year><volume>39</volume><fpage>810</fpage><lpage>814</lpage></element-citation></ref><ref id="b52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugano</surname><given-names>N</given-names></name><name><surname>Kawamoto</surname><given-names>K</given-names></name><name><surname>Numazaki</surname><given-names>H</given-names></name><name><surname>Murai</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name></person-group><article-title>Detection of mitochondrial DNA mutations in human gingival tissues</article-title><source>Journal of Oral Science</source><year>2000</year><volume>42</volume><fpage>221</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">11269380</pub-id></element-citation></ref><ref id="b53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takane</surname><given-names>M</given-names></name><name><surname>Sugano</surname><given-names>N</given-names></name><name><surname>Iwasaki</surname><given-names>H</given-names></name><name><surname>Iwano</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name></person-group><article-title>New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals</article-title><source>Journal of Periodontology</source><year>2002</year><volume>73</volume><fpage>551</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">12027259</pub-id></element-citation></ref><ref id="b54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonetti</surname><given-names>MS</given-names></name><name><surname>Chapple</surname><given-names>ILC</given-names></name></person-group><article-title>Nutritional modulation of periodontal inflammation. In: Biological Approaches to the Development of Novel Periodontal Therapies Group 3 – Consensus of the 7th European Workshop on Periodontology</article-title><source>Journal of Clinical Periodontology</source><year>2011</year><volume>38</volume><issue>s11</issue><fpage>114</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">21323708</pub-id></element-citation></ref><ref id="b55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dyke</surname><given-names>TE</given-names></name></person-group><article-title>The management of inflammation in periodontal disease</article-title><source>Journal of Periodontology</source><year>2008</year><volume>79</volume><fpage>1601</fpage><lpage>1608</lpage><pub-id pub-id-type="pmid">18673016</pub-id></element-citation></ref><ref id="b56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Velden</surname><given-names>U</given-names></name><name><surname>Kuzmanova</surname><given-names>D</given-names></name><name><surname>Chapple</surname><given-names>ILC</given-names></name></person-group><article-title>Micronutritional approaches to periodontal therapy</article-title><source>Journal of Clinical Periodontology</source><year>2011</year><volume>38</volume><issue>s11</issue><fpage>42</fpage><lpage>58</lpage></element-citation></ref><ref id="b57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>PF</given-names></name><name><surname>Ho</surname><given-names>KY</given-names></name><name><surname>Ho</surname><given-names>YP</given-names></name><name><surname>Wu</surname><given-names>YM</given-names></name><name><surname>Yang</surname><given-names>YH</given-names></name><name><surname>Tsai</surname><given-names>CC</given-names></name></person-group><article-title>The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin-1b in gingival crevicular fluid: implications for oxidative stress in human periodontal diseases</article-title><source>Journal of Periodontal Research</source><year>2004</year><volume>39</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">15324348</pub-id></element-citation></ref><ref id="b58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Weijden</surname><given-names>GA</given-names></name><name><surname>Timmermann</surname><given-names>MF</given-names></name></person-group><article-title>A systematic review on the clinical efficacy of subgingival debridement in the treatment of chronic periodontitis</article-title><source>Journal of Clinical Periodontology</source><year>2002</year><volume>29</volume><issue>Suppl. 3</issue><fpage>55</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12787207</pub-id></element-citation></ref><ref id="b59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wennström</surname><given-names>JL</given-names></name><name><surname>Tomasi</surname><given-names>C</given-names></name><name><surname>Bertelle</surname><given-names>A</given-names></name><name><surname>Dellasega</surname><given-names>E</given-names></name></person-group><article-title>Full-mouth ultrasonic debridement versus quadrant scaling and root planing as an initial approach in the treatment of chronic periodontitis</article-title><source>Journal of Clinical Periodontology</source><year>2005</year><volume>32</volume><fpage>851</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">15998268</pub-id></element-citation></ref><ref id="b60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>DS</given-names></name></person-group><article-title>Implementation of SI units for clinical laboratory data</article-title><source>Annals of Internal Medicine</source><year>1987</year><volume>106</volume><fpage>114</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">3789557</pub-id></element-citation></ref></ref-list><sec sec-type="supplementary-material"><title>Supporting Information</title><p>Additional Supporting Information may be found in the online version of this article:</p><p><bold>Table S1.</bold> Primary clinical outcomes pre- and post-therapy (mean ± SD).</p><supplementary-material content-type="local-data" id="SD1"><media xlink:href="jcpe0039-0062-SD1.doc" xlink:type="simple" id="d32e3470" position="anchor" mimetype="application" mime-subtype="msword"></media></supplementary-material><p><bold>Table S2.</bold> Secondary clinical outcomes pre- and post-therapy (mean ± SD).</p><supplementary-material content-type="local-data" id="SD2"><media xlink:href="jcpe0039-0062-SD2.doc" xlink:type="simple" id="d32e3476" position="anchor" mimetype="application" mime-subtype="msword"></media></supplementary-material><p>Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.</p></sec></back></article>